9
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 117-141 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Nanoparticle of poly(epsilon-caprolactone) with digitoxin. II. Stability in biological fluids. ABERTURAS, M. R., MOLPECERES, J., GUZMAN, M., FESSI, H., PUISEUX, F., and DEVISSAGUET, J. P., An. R. Acad. Farm., 1991, 57, (1), 5–14.
  • Sealant effect of dika fat in the microcapsules of a highly water-soluble drug: chloroquine phosphate. AD1KWU, M. U., CHUKWU, A., and CHIORI, C. 0., Acta Pharm. Jugosl., 1991,41, (1), 61–65.
  • Effect of cholesterol in various liposomal compositions on the in vivo toxicity, therapeutic efficacy, and tissue distribution of amphotericin B. AHMAD, I., SARKAR, A. K., and BACHHAWAT, B. K., Biotechnol. Appl. Biochem., 1990, 12, (5), 550–556.
  • Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice. AHMAD, I., SARKAR, A. K., and BACHHAWAT, B. K., Indian J. Biochem. Biophys., 1990, 27, (6), 370–374.
  • Immunohistochemical detection of tumor specific surface protein incorporated into lipo-somes. AHN, Y. H., and HAN, G. S., Korean J. Biochem., 1990, 22, (1), 65–72.
  • Lymphotropic and sustained delivery of aclarubicin from lactic acid-oligomer microspheres. Effect of molecular weight of lactic acid-oligomer and of size of microspheres. AKAMISAKA, S., MURAKAMI, M., YOSHIKAWA, H., TAKADA, K., MURANISHI, S., WADA, R., TABATA, Y., HYON, S. H., and IKADA, Y., Drug Delivery Syst., 1991, 6, (1), 35–39.
  • Effect of microsphere size and formulation factors on drug release from controlled-release furosemide microspheres. AKBUGA, J., Drug. Dev. Thd. Pharm., 1991, 17, (4), 593–607.
  • Combined effects of hepatic arterial embolization using degradable starch microspheres (DSM) in hyperthertnia for liver cancer. AKUTA, K., ABE, M., KONDO, M., YOSHIKAWA, T., TANAKA, Y., YOSHIDA, M., MIURA, T., NAKAO, N., ONOYAMA, Y. et al., Int. J. Hyperthermia, 1991, 7, (2), 231–242.
  • Release of furosemide from sustained release microcapsules prepared by phase separation technique. AL GOHARY, 0., and EL GAMAL, S., Drug Dev. Ind. Pharm., 1991, 17, (3), 443–450.
  • Thermodynamic and structural effects of propranolol on DPPC liposomes. ALBERTINI, G., DONATI, C., PHADKE, R. S., PONZI Boss', M. G., and RUSTICHELLI, F., Chem. Phys. Lipids, 1990, 55, (3), 331–337.
  • Radiometric effects on absorbing microspheres. ALLEN, T. M., BUEHLER, M. F., and DAVIS, E. J., J. Colloid Interface Sc., 1991, 142, (2), 343–356.
  • Synthesis of protein-coated gelatin microspheres and their use as microcarriers for cell culture. Part I. Derivatization with native collagen. ALTANKOV, G., BRODVAROVA, I., and RASHKOV, I., J. Biomater. Sci. Polym. Ed., 1991, 2, (2), 81–89.
  • Antibodies to cholesterol, cholesterol conjugates and liposomes: implications for atheroscle-rosis and autoimmunity. ALVING, C. R., and SWARTZ, G. M. JR., Crit. Rev. Immunol., 1991, 10, (5), 441–453.
  • Effect on cerebral blood flow of orally administered indomethacin-loaded poly(isobutylcyanoacrylate) and poly(DL-lactide) nanocapsules. AMMOURY, N., FESSI, H., DEVISSAGUET, J. P., ALLix, M., PLOTKINE, M., and BouLu, R. G., J. Pharm. Pharmacol., 1990,42, (8), 558–561.
  • Jejunal absorption, pharmacological activity, and pharmacokinetic evaluation of indomethacin-loaded poly(d,l-lactide) and poly(isobutyl-cyanoacrylate) nanocapsules in rats. AMMOURY, N., FESSI, H., DEVISSAGUET, J. P., DUBRASQUET, M., and BENITA, S., Pharm. Res., 1991, 8, (1), 101–105.
  • Physicochemical characterization of polymeric nanocapsules and in vitro release evaluation of indomethacin as a drug model. AMMOURY, N., FESSI, H., DEVISSAGUET, J. P., PUISIEUX, F., and BENITA, S., STP Pharma., 1989, 5, (10), 647–651.
  • Optimization and upscaling of doxorubicin-containing liposomes for clinical use. AMSELEM, S., GABIZON, A., and BARENHOLZ, Y., J. Pharm. Sci., 1990, 79, (12), 1045–1052.
  • Evaluation of a new extrusion device for the production of stable oligolamellar liposomes in a liter scale. AMSELEM, S., GABIZON, A., and BARENHOLZ, Y., J. Liposome Res., 1990, 1, (3), 287–301.
  • Identification of grafted neurons with fluorescent-labelled microbeads. ARBUTHNOTT, G. W., and DUNNETT, S. B., Prog. Brain Res., 1990, 82, 385–390.
  • Gray scale characteristics of the microencapsulated acrylate process of imaging. ARNEY, J. S., and DOWLER, J. A., Rad Tech '90 North Am. Conf. Proc., RadTech Int. North Am., Northbrook, III, USA, publ. 1990, pp. 446–454.
  • Effect of sodium chloride on pro-oxidant activity of copper(II) in peroxidation of phospholipid liposomes. ARNOLD, A. R., BASCETTA, E., and GUNSTONE, F. D., J. Food Sri., 1991, 56, (2), 571–573.
  • Influence of dextran sulfate on the fusion of Sendai virus with liposomes. ARNOLD, K., FLANAGAN, T. D., and Otno, S., Biomed. Biochim. Acta, 1990, 49, (7), 633–635.
  • Interaction of dextran sulfate with phospholipid surfaces and liposome aggregation and fusion. ARNOLD, K., OHKI, S., and KRUMBIEGEL, M., Chem. Phys. Lipids, 1990, 55, (3), 301–307.
  • Liposomes from soya phospholipids as percutaneous drug carriers. 2nd communication: quantitative in vivo investigations with radioactively labelled liposomes. ARTMANN, C., RODING, J., GHYCZY, M., and PRATZEL, H. G., Arzneimittelforschung, 1990, 40, (12), 1365–1368.
  • Liposomes from soya phospholipids as percutaneous drug carriers. 1st communication: qualitative in vivo investigations with antibody-loaded liposomes. ARTMANN, C., RODING, J., GHYCZY, M., and PRATZEL, H. G., Arzneimittelforschung, 1990, 40, (12), 1363–1365.
  • Prolonging the shelflife of liposomes for ophthalmic use. Assn., K. K., FOURAKER, B. D., SCHANZLIN, D. J., and WEINREB, R. N., Invest. Ophthalmol, Visual Sci., 1991, 32, (4), 1292.
  • Liposomes as carriers for allergy immunotherapy. AUDERA, C., RAMIREZ, J., SOLER, E., and CARREIRA, J., Clin. Exp. Allergy, 1991, 21, (1), 139–144.
  • Possibilities and problems of stabilization of liposomes by freezing and lyophilization: 2nd comm. Influence of sucrose and sucrose palmitate stearate on the behavior of lecithin cholesterol liposomes. AUSBORN, M., and Nufmr, P., PZ (Pharm. Zig) Wiss, 1991, 136, (I), 17–24.
  • Freeze-drying of submicron colloidal carriers. AUVILLAIN, M., CAVE, G., FESSI, H., and DEVISSAGUET, J. P., STP Pharma, 1989, 5, (11), 738–744.
  • Photosensitized destruction of human bladder carcinoma cells treated with chlorin e6-conjugated microspheres. BACHOR, R., SHEA, C. R., GILLIES, R., and HASAN, T., Proc. Natl. Acad. Sci. USA, 1991, 88, (4), 1580–1584.
  • Bioavailability of erythromycin enteric-coated microcapsules in rabbits. BA FENGGING, ZHAO YANG, MA CHUANG, YANG YONGHUI and Qx KUISHENG, Kangshengsu, 1990, 15, (5), 382–383.
  • Nonuniform alveolar uptake of liposome-encapsulated copper zinc superoxide dismutase and catalase. BAKER, R. R., JILLING, T., MATALON, S., and KIRK, K. L., Am. Rev. Respir. Dis., 1991, 143, (4, part 2), A303.
  • Liposomes and lipid carriers in the treatment of microbial infections. BAKKER-WOUDENBERG, I. A. J. M., and LOKERSE, A. F., Scand. J. Infect. Dis. Supp1., 1990, (74), 34–41.
  • Increased efficacy of ganciclovir and foscarnet inhibition of cytomegalovirus replication in vitro by encapsulation in liposomes. BAKKER-WOUNDENBERG, I. A. J. M., LOKERSE, A. E., and TEN-KATE, M., Scand. J. Infect. Dis. Suppl., 1990, (74), 54–57.
  • Regional chemotherapy for colorectal hepatic metastases using degradable starch micro-spheres. A review. BALL, A. B., Acta Oncol., 1991, 30, (3), 309–313.
  • Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes. BALLY, M. B., NAYAR, R., MASIN, D., CULLIS, P. R., and MAYER, L. D., Cancer Chemother. Pharmacol., 1990,27, (1), 13–19.
  • Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion, and liposomal superoxide distnutase. BANDO, K., SCHUELER, S., CAMERON, D. E., DEVALERIA, P. A., HATANAKA, M., CASALE, A. S., ZEBLEY, M. A., HUTCHINS, G. M., REITZ, B. A., and BAUMGARTNER, W. A., J. Heart Lung Transplant., 1991, 10, (2), 304–309.
  • Liposomal doxorubicin TLC-D99 in experimental and clinical breast cancer is effective and less toxic. BATIST, G., MAYER, L., PILKIEWICZ, F., WANG, T., SKRUTKOWSKA, M., ZUKIWSKI, A., AHLGREN, P., SKELTON, J., GRUNGER, P., and LEYLAND JONES, S. B., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 183.
  • Small scale field trial with polystyrene beads for the control of mosquito breeding. BEKHEIT, S. S., EL AGROUDY, R. m MIKHAIL, M. W., II3RAHIM, S. H., and MONEIM, M. M., J. Egypt. Soc. Parasitol., 1991, 21, (1), 179–182.
  • Modeling of physical processes using monosized polymer particles. BERGE, A., ELLINGSEN, T., SKJELTORP, A. T., and UGELSTAD, J., NATO ASI Ser., Ser. C, 1990, 303 (Sci. Methods Study Polym. Colloids Appl.), 435–452.
  • Cosmetic application of vitamin E encapsulated in dimyristoylphosphatidylcholine lipo-somes. BERROCAL, M. C., and ABEGER, A., An. R. Acad. Farm., 1990, 56, (1), 111–119.
  • Use of liposomes, viral capsids, and nanoparticles as DNA carriers. BERTLING, W. M., GAREIS, M., PASPALEEVA, V., ZIMMER, A., KREUTER, J., NUERNBERG, E., and HARRER, P., Biotechnol. Appl. Biochem., 1991, 13, (3), 390–405.
  • NMR study of the interaction of beta-blockers with sonicated dimyristoylphosphatidylcholine liposomes in the presence of praseodymium cation. BETAGERI, G. V., THERIAULT, Y., and ROGERS, J. A., Membr. Biochem., 1989, 8, (4), 197–206.
  • Computer simulation for in vitro drug release kinetics from microcapsules. BHANJA, R. S., NANDY, A., ROYCHOWDHURY, T., and PAL, T. K., Indian J. Phar. Sci., 1990, 52, (5), 233–239.
  • Detection with magnetic microcapsules in human GI tract of putative hydroxyl radical precursors. BINGHAM, S. A., SHAH, A. B., ELLUL, A., and O'NEILL, I. K., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 170.
  • Dark interaction of 5-methoxypsoralen and 8-methoxypsoralen with erythrocyte ghosts: A fluorescence and circular dichroism study. BLAB, J., MILHAUD, J., BOLARD, J., and VIGNY, P., J. Photochem. Photobiol. B Biol., 1991, 9, (2), 161–170.
  • Production of uniform drops of viscous liquids using a coaxial airstream. BLYSNIUK, J. W., and SEFTON, M. V., Can. J. Chem. Eng., 1991, 69, (1), 245–250.
  • Pseudoephedrine hydrochloride microspheres formulated into an oral suspension dosage form. BODMEIER, R., CHEN, H., TYLE, P., and JARosz, P., J. Controlled Release, 1991, 15, (1), 65–77.
  • Process and formulation variables affecting the drug release from chlorpheniramine maleate-loaded beads coated with commercial and self-prepared aqueous ethyl cellulose pseudolatexes. BODMEIER, R., and PAERATAKUL, 0., Int. J. Pharm., 1991, 70, (1-2), 59–68.
  • Liposomal amphotericin B inhibits in vitro T-lymphocyte response to antigen. BOGUS, J. M., CHANG, N. H., and GoLNDALRAR, A., Antimicrob. Agents Chemother., 1991, 35, (5), 879–885.
  • PaImitate binding to and efflux kinetics from human erythrocyte ghost. BOJESEN, I. N., and BOJESEN, E., Biochim. Biophys. Acta, 1991, 1064, (2), 297–307.
  • Increase of lipid fluidity and suppression of proliferation resulting from liposome uptake by human keratinocyte in Vitro. BONNEKOH, B., RODING, J., KRUEGER, G. R., GHYCZY, M., and MAHRLE, G., Br. J. Dermatol., 1991, 124, (4), 333–340.
  • Characterizing mechanisms of hepatic bile acid transport utilizing isolated membrane vesicles. BOYER, J. L., and MEIER, P. J., Methods Enzymol., 1990, 192, 517–533.
  • Preparation and characterization of liposomes with a high capacity for encapsulation in bilberry anthocyanosides. BRAMBILLA, G., and INGANNI, G., Cosmet. News, 1989, 68, 303–307.
  • Adsorption of hematoporphyrin onto poly(alkyl cyanoacrylate) nanoparticles: carrier capacity and drug release. BRASSEUR, N., BRAULT, D., and COUVREUR, P., Int. J. Pharm., 1991, 70, (1-2), 129–135.
  • Development of pH-sensitive liposomes for delivery of bioactive molecules to animal cells. BROWN, P. M., McGill University, Montreal, PQ, Canada, Dissertation, 1990, No pagination given.
  • Growth instabilities of vesicles. BRUINSMA, R., Colloq. Phys. (C7, Int. Workshop Geom. Interfaces, 1990), publ. 1990, C7-53-C7–71.
  • Encapsulated hepatocytes for controlling hyperbilirubinemia in Gunn rats. BRUNI, S., and CHANG, T. M. S., Int. J. Artif. Organs, 1991, 14, (4), 239–241.
  • Characterization of albumin acacia complex coacervation. BURGESS, D. J., KwoR, K. K., and MEGREMIS, P. T., J. Pharm. Pharmacol., 1991, 43, (4), 232–236.
  • Immunoisolation of porcine islets of Langerhans within alginipolyaminoacidic micro-capsules. CALAFIORE, R., BASTE, G., FALORNI, A. JR., AVELLINI, L., and BRUNETTI, P., HAM. Metab. Res. Suppl., 1990, 25, 213–214.
  • In vitro phagocytosis of fluorescent microspheres by coronary vascular endothelial cell lines from human heart transplant recipients. CASE, T., WAY, D., WITTE, M., LARSON, D., WITTE, C., and COPELAND, J., Clin. Res., 1991, 39, (2), 146A.
  • Macromolecular prodrugs interaction with mixed lipid membrane. A calorimetric study of naproxen linked to polyaspartamide interacting with phosphatidylcholine and phosphatidylcholine-phosphatidic acid vesicles. CASTELIA, F., GIAMMONA, G., RAUDINO, A., and PtioLisi, G., Int. J. Pharm., 1991, 70, (1-2), 43–52.
  • An infrared spectroscopic study of specifically deuterated fatty-acyl methyl groups in phosphatidylcholine liposomes. CASTRESANA, J., VAI.PUESTA, J. M., ARRONDO, J. L., and GONI, F. M., Biochim. Biophys. Acta, 1991, 1065, (1), 29–34.
  • The potential of microencapsulated urease-zeolite oral sorbent for the removal of urea in uremia. CATTANEO, M. V., McGill University, Montreal, PQ, Canada, Dissertation, 1990, No pagination given.
  • The action of hydrogen peroxide on the formation of thiobarbituric acid-reactive material from microsomes, liposomes or from DNA damaged by bleomycin or phenanthroline. Artefacts in the thiobarbituric acid test. CECCHINI, R., ARUOMA, 0. I., and HALLI WELL, B., Free Radic. Res. Commun., 1990, 10, (4-5), 245–258.
  • Immunogenicity of liposome-associated oral cholera vaccine prepared from combined Vibrio cbolerae antigens. CHAICUMPA, W., PARAIRO, J. R., NEW, R. C., PONGPONRATN, E., RUANGKUNAPORN, Y., TAPCHAISRI, P., and CHONGSA'NGUAN, M., Asian PAC. J. Allergy Itnmunol., 1990, 8, (2), 87–94.
  • Use of transmembrane pH gradients and A23187 to produce dense iron liposomes. CHAKRABARTI, A. C., VEIRO, J. A., WONG, N., and CuLLis, P. R., Biochem. Soc. Trans., 1990, 18, (5), 946–947.
  • Resonance structures in elastic and Raman scattering from microspheres. CHAN, C. K., FLAGAN, R. C., and SEINFELD, J. H., Appl. Opt., 1991, 30, (4), 459–467.
  • The effect of various polymeric coating systems on the dissolution and tableting properties of potassium chloride microcapsules. CHANG, R. K., and RUDNIC, E. M., Int. J. Pharm., 1991, 70, (3), 261–270.
  • Biotechnological and medical applications based on immobilization of hepatocytes, micro-organisms, or enzyme systems by microencapsulation in artificial cells. CHANG, T. M., Ann. N.Y. Acad. Sci., 1990, 613, 109–115.
  • Efficiency of liposomal ATP in cerebral ischemia bioavailability features. CHAPAT, S., FREY, V., CLAPERON, N., BOUCHAUD, C., PUISIEUX, F., COUVREUR, P., ROSSIGNOL, P., and DELATTRE, J., Brain Res. Bull., 1991, 26, (3), 339–342.
  • Phospholipid liposomes-surfactant interactions as predictors of skin irritation. CHARAF, U. K., and HART, G. L., J. Soc. Cosmet. Chem., 1991, 42, (2), 71–86.
  • Drugs and the pharmaceutical sciences, Vol. 45. Biodegradable polymers as drug delivery systems. CHASIN, M., and LANGER, R., M. Chasin and R. Langer (Eds). Drugs and the Pharmaceutical Sciences, Vol. 45. Biodegradable Polymers as Drug Delivery Systems. 347 p. Marcel Dekker, Inc., New York, N.Y., USA, 1990.
  • Controlled theophylline release from microcapsules of acrylic and methacrylic acid ester copolymer. CHATTARAJ, S. C., DAS-SUDIP, K., KARTHIKEYAN, M., GHOSAL, S. K., and GUPTA, B. K., Drug Dev. Ind. Pharm., 1991, 17, (4), 551–560.
  • Role of nicotinic acid as modulator of liposomal microviscosity. CHATTERJEE, M., BASU, R., and NANDY, P., J. Biosci., 1990, 15, (3), 145–148.
  • Toxic effect of liposome-encapsulated methotrexate on bone marrow cells in mice. CHEN FANGHONG, ZHENG SHU, Yu HAI and XIE XINGHUI, Zhejiang Yike Daxue Xuebao, 1990, 19, (5), 198–200.
  • Tissue distribution of liposome-encapsulated MTX in S-180-bearing mice. CHEN FANGHONG, ZHENG SHU, Yu HAI and XIE XINGHUI, Zhejiang Yike Daxue Xuebao, 1990, 19, (6), 264–266.
  • Targeting drug delivery system-methotrexate pharmacokinetics after hepatic arterial embolization with microspheres. CHEN, Q. H., Lu, W. G., GE, Q. H., HE, W., XIE, X. H., YANG, W. Z., and UN, G., Yaoxue Xuebao, 1991, 26, (2), 139–143.
  • Study on preparation and characters of microcapsules of garlic oil by spray technique. CHEN, Q. H., Lu, W. G., and WANG, W. M., Zhonggue Yiyao Gongye Zazhi, 1990, 21, (12), 540–544.
  • Time-resolved polarization luminescence spectroscopy of hematoporphyrin in liposomes. CHERNYAEVA, E. B., GOLUBEVA, N. A., KOROTEEV, N. I., LOBANOV, 0. V., and VARDANYAN, A., Proc. SPIE Int. Soc. opt. Eng., 1991, 1402 (USSR-CSFR Jt. Semin. Nonlinear Opt. Control. Diagn., Model. Biophys. Processes, 1990) 7–10.
  • Release of cytarabine from biodegradable poly(gamma-benzyl L-glutamate)/poly(ethylene oxide)/poly(gamma-benzyl L-glutamate) block copolymer microsphere. CH0 -CtioNG-SU, PARK-JUNG-WOONG, KWON-JOONG-KUEN, JO-BYUNG-WOOK, LEE-KANG-CHOON, KIM-KEA-YONG and SUNG-YONG-KIEL, Pollimo, 1991, 15, (1), 27–33.
  • Microencapsulation of pesticides by interfacial polymerization. 1. Polyurethane micro-capsules containing oil-soluble drug. CHOI-KIL-YEONG, MIN-KYOUNG-SUK, PARK-IN-HWAN, KIM-KWANG-S00 and CHANG-TAEHYUN, Pollimo, 1990, 14, (4), 392–400.
  • Study of interactions between a new potent analgesic and liposomes by differential scanning calorimetry. CHOLI,I, A. L., OKUZUMI, M., PEJAVER, S. K., and VENTURELLA, V. S., Abstr. Par. Am. Chem. Soc., 1991, 201, (1–2), Anyl. 97.
  • The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. CHONN, A., CuLLts, P. R., and DEVINE, D. V., J. Immunol., 1991, 146, (12), 4234–4241.
  • Preparation and evaluation of cellulose acetate microcapsules of theophylline. CHOWDARY, K. P. R., and RATNA, J. V., Indian J. Pharm. Sci., 1990, 52, (6), 279–281.
  • Interaction of influenza hemagglutinin amino-terminal peptide with phospholipid vesicles: a fluorescence study. CLAGUE, M. J., KNUTSON, J. R., BLUMENTHAL, R., and HERRMANN, A., Biochemistry, 1991, 30, (22), 5491–5497.
  • Binding and diffusion kinetics of the interaction of a hydrophobic potential-sensitive dye with lipid vesicles. CLARKE, R. J., Biophys. Chem., 1991, 39, (1), 91–106.
  • Reduced toxicity of adriamycin by incorporation into ion exchange microspheres: a therapeu-tic study using a rat liver tumor model. CODDE, J. P., BURTON, M. A., KELLEHER, D. K., ARCHER, S. G., and GRAY, B. N., Anticancer Res., 1990, 10, (6), 1715–1718.
  • Lipid-alginate interactions render changes in phospholipid bilayer permeability. COHEN, S., BANO, M. C., CHOW, M., and LANGER, R., Biochim. Biophys. Acta, 1991, 1063, (1), 95–102. Liposome-gel compositions as immunization vehicles for vaccines. COHEN, S., CHOW, M., and
  • LANGER, R., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (6), A1626.
  • Successful treatment of cryptococcal meningitis with liposomal amphotericin B after failure of treatment with fluconazole and conventional amphotericin B (letter). COKER, R., TOMLINSON, D., and HARRIS, J., AIDS, 1991, 5, (2), 231–232.
  • Tissue distribution and bioactivity of amphotericin B administered in liposomes to cancer patients. COLLETTE, N., VAN DER AUWERA, P., MEUNIER, F., LAMBERT, C., SCGLIER, J. P., and COUNE, A., J. Antimicrob. Chemother., 1991, 27, (4), 535–548.
  • Proton and divalent cations induce synergistic but mechanistically different destabilizations of pH-sensitive liposomes composed of dioleoyl phosphatidylethanolamine and oleic acid. COLLINS, D., CONNOR, J., TING BEALL, H. P., and HUANG, L., Chem. Phys. Lipids, 1990,55, (3), 339–349.
  • Effect of phagocytosis of erythrocytes and erythrocyte ghosts on macrophage phagocytic function and hydrogen peroxide production. COMMINS, L. M., LOEGER1NG, D. J., and GUDEWICZ, P. W., Inflammation, 1990, 14, (6), 705–716.
  • Adjuvant effect of liposomes in the autoimmune response to rat male accessory glands. CORREA, S. G., and R1ERA, C. M., Immunol. Lett., 1991, 28, (1), 39–46.
  • Microencapsulation scale-up considerations and production technology. CRAINICH, V. A. JR., P. Tyle (ed.), Drugs and the Pharmaceutical Sciences, Vol. 41: Specialized Drug Delivery Systems: Manufacturing and Production Technology. 475 p. Marcel Dekker, Inc., New York, N.Y., USA, 1990, pp. 221–256.
  • Solution effects on the thermotropic phase transition of unilamellar liposomes. CROWE, L. M., and CROWE, J. H., Biochim. Biophys. Acta, 1991, 1064, (2), 267–274.
  • Covalent coupling of doxorubicin in protein microspheres is a major determinant of tumour drug disposition. CUMMINGS, J., WILLMOTT, N., MARLEY, E., and SMYTH, J., Biochem. Pharmacol., 1991, 41, (12), 1849–1854.
  • Liposome-delivered silicon(IV)-naphthalocyanine as a photodynamic sensitizer for experi-mental tumors: pharmacokinetic and phototherapeutic studies. Cuomo, V., JoEt, G., RIHTER, B., KENNEY, M. E., and RODGERS, M. A. J., Br. J. Cancer, 1990, 62, (6), 966–970.
  • A phase I and comparative pharmacologic study of standard and liposome-encapsulated doxorubicin dox and lipodox. CURRIE, V. E., MUIND1, J., and YOUNG, C. W., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 201.
  • Immobilization of membrane enzymes into magnetizable, phospholipid bilayer-coated, inorganic colloids. CUYPER, M. DE., and JoNtAu, M., Prog. Colloid Polym. Sci., 1990, 82 (Surfactants Macromol.: Self-Assem. Interfaces Bulk), 353–359.
  • Binding of 5-fluorouracil to microsphere starch particles. CZEJKA, M., and SCHULLER, J., Arch. Pharm. (Weinheim), 1991, 324, (1), 53.
  • Comparative study of microencapsulated rat islets implanted in different diabetic models in mice. DARQUY, S., CH1CHEPORTICHE, D., CAPRON, F., BOITARD, C., and REACH, G., Horm. Metab. Res. Suppl., 1990, 25, 209–213.
  • Two-dimensional crystals of streptavidin on biotinylated lipid layers and their interactions with biotinylated macromolecules. DARST, S. A., AHLERS, M., MELLER, P. H., KUBALEK, E. W., BLANKENBURG, R., Rim, H. 0., RINGSDORF, H., and KORNBERG, R. D., Biophys. J., 1991, 59, (2), 387–396.
  • Liposomal amphotericin B in drug-resistant visceral leishmaniasis. DAVIDSON, R. N., CROFT, S. L., SCOTT, A., MAIN, M., MOODY, A. H., and BRYCESON, A. D., Lancet, 1991, 337, (8749), 1061–1062.
  • Mechanistic aspects of the adsorption of phospholipids onto lauric acid stabilized magnetite nanocolloids. DE CUYPER, M., and JoNtAu, M., Langmuir, 1991, 7, (4), 647–652.
  • Exchange of retinoids between lipid vesicles and rod outer segment membranes. DE-GRIP, W. J., and DAEMEN, F. J., Methods Enzymol., 1990, 189, 402–411.
  • Poly(diethyl methylidenemalonate) nanoparticles as a potential drug carrier: preparation, distribution and elimination after intravenous and peroral administration to mice. DE-KEYSER, J. L., POUPAERT, J. H., and DUMONT, P., J. Pharm. Sci., 1991, 80, (1), 67–70.
  • Permeability changes of phospholipid vesicles caused by surfactants. DE-LA-MAzA, A., LEAL, J. S., PARRA, J. L., GARCIA, M. T., and RIBOSA, I., J. Am. Oil Chem. Soc., 1991, 68, (5), 315–319.
  • Giant liposomes as model membranes for immunological studies: spontaneous insertion of purified Kl-antigen (poly-alpha-2,8-NeuAc) of Escherichia coll. DECHER, G., RINGSDORF, H., VENZMER, J., BITTER-SUERMANN, D., and WEISGERBER, C., Biochim. Biophys. Acta, 1990,1023, (3), 357–364.
  • Adsorption of phosphatidylcholine liposomes at the air-water interface. DENIZOT, B. A., TCHORELOFF, P. C., PROUST, J. E., PUISIEUX, F., LINDENBAUM, A., and DEHAN, M., J. Colloid Interface Sci., 1991, 143, (1), 120–126.
  • Muramyltripeptide-phosphatidylethanolamine (MTP-PE) entrapped into liposomes: A way to induce high serum levels of tumor necrosis factor (TNE-alpha) in lung cancer patients. DIANA, D., BODY, J. J., MARKIEWICZ, E., and SCULIER, J. P., PrOC. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 193.
  • Preparation of silica glass microspheres by sol-gel processing. DING, J. Y., and DAY, D. E., J. Mater. Res., 1991, 6, (1), 168–174.
  • Therapeutic effects of EDTA-fluorocarbon microspheres in cadmium intoxication. DING XUNCHENG, LIU CHUNFANG, Li XINJIAN, JINGWU DONG and XIANG CUIQIN, Weisheng Dulixue Zazhi, 1990, 4, (4), 221–224.
  • Size and stability of dipalmitoylphosphatidylcholineicholesterol unilamellar vesicles are affected by interaction with proteins. Dim, L., Di-GiuLio, A., PAVAN, A., RAVAGNAN, G., and MOSSA, G., Biochim. Biophys. Acta, 1991, 1062, (1), 108–112.
  • A study of feeding in predacious ciliates using prey ciliates labeled with fluorescent microspheres. DOI.AN, J. R., and COATS, D. W., J. Plankton Res., 1991, 13, (3), 609–628.
  • Improvement of amphotericin B activity during experimental cryptococcosis by incorpor-ation into specific irnmunoliposomes. DROMER, F., BARBET, J., BoLARD, J., CIIARREIRE, J., and YENI, P., Antimicrob. Agents Chemother., 1990, 34, (11), 2055–2060.
  • The uptake of noradrenaline by human red blood cells and ghosts. DUNK, C. R., University of Leicester, Leicester, UK Dissertation, 1989, 330 pp.
  • Sustained in vitro activity of human albumin microspheres containing chlorhexidine dihydrochloride against bacteria from cultures of organisms that cause urinary tract infections. EGBARIA, K., and FRIEDMAN, M., Antimicrob. Agents Chemother., 1990,34, (11), 2118–2121.
  • Topical application of liposomally entrapped ciclosporin evaluated by in vitro diffusion studies with human skin. EGBARIA, K., RAMACHANDRAN, C., and WEINER, N., Skin Pharmacol., 1991,4, (1), 21–28.
  • Topical application of liposomal preparations. EGBARIA, K., and WEINER, N., Cosmet. Toiletries, 1991, 106, (3), 79–80. 82, 84, 86–89. 92–93.
  • Interaction of amikacin loaded nanoparticles with phosphatidylcholine monolayers as membrane models. EGEA, M. A., VALLS, 0., ALSINA, M. A., GARCIA, M. L., LOSA, C., VILA-JATO, J. L., and ALONSO, M. J., Int. J. Pharm., 1991, 67, (2), 103–112.
  • Clinical experience of targeted therapy. EICHLER, H. G., Biotherapy, 1991, 3, (1), 77-85. Pharmacokinetics and bioavailability of norfloxacin microcapsules. EL-DIEN, E. E. Z., Pharm. Ind., 1991, 53, (1), 87–90.
  • Dissolution of furosemide from sustained release microcapsules prepared by the phase separation technique. EL-GOHARY, 0., and EL-GAMAL, S., Acta Pharm. Jugosl., 1991, 41, (1), 55–60.
  • Decrease of liver energy charge, ATP and glutathione at concomitant intra-arterial administr-ation of adriamycin and degradable starch microspheres in rat. EL-HAG, I. A., Roos, G., and STENRAM, U., Sel. Cancer They., 1990, 6, (3), 135–144.
  • A low-cost automated device incorporating a hollow fiber filtration cartridge for large-scale production of ghosts from human erythrocytes. EL-OUGGOUTI, S., TRUSKOLASKI, A. BUSSEL, A., DHERMY, D., and BERTRAND, 0., J. Biochem. Biophys. Methods, 1990, 21, (4), 299–309.
  • Biodegradable microspheres as a vaccine delivery system. ELDRIDGE, J. H., STAAS, J. K., MEULBROEK, J. A., MCGHEE, J. R., TICE, T. R., and GILLEY, R. M., Mol. Immunol., 1991, 28, (3), 287–294.
  • Liposome-encapsulated cyclosporin A delivered by collagen shields to rabbit eyes. ELKINS, B., PLEYER, U., RUECKERT, D., and MONDINO, B. J., Invest. Ophthalmol. Visual Sci., 1991, 32, (4), 1292.
  • Controlled release of 5-fluoro-2'-deoxyuridine by the combination of prodrug and polymer matrix. ENDOH, H., KAWAGUCHI, T., SExi, T., HASEGAWA, T., and JuNii, K., Chem. Pharm. Bull., 1991, 39, (2), 458–464.
  • Liposomes having high sensitivity to odorants. ENOMOTO, S., KASHIWAYANAGI, M., and KURIHARA, K., Biochim. Biophys. Acta, 1991, 1062, (1), 7–12.
  • A salt-activated inositol 1,3,4,5-tetrakisphosphate 3-phosphatase at the inner surface of the human erythrocyte membrane. ESTRADA-GARCIA, T., CRAXTON, A., KIRK, C. J., and MICHELL, R. H., Proc. R. Soc. Lond. Ser. B Biol. Sci., 1991, 244, (1309), 63–68.
  • Phase I study of liposomal MTP-PE-activated autologous monocytes administered intraperi-toneally to patients with peritoneal carcinomatosis. FARADJI, A., BOHBOT, A., FROST, H., SCHMITT-GOGUEL, M., SIEFERT, J. C., DUFOUR, P., EBER, M., LALLOT, C., WIESEL, M. L., BERGERAT, J. P. et al., J. Clin. Oncol., 1991, 9, (7), 1251–1260.
  • Ampicillin-loaded liposomes and nanoparticles: comparison of drug loading, drug release and in vitro antimicrobial activity. FATTAL, E., ROJAS, J., ROBLOT-TREUPEL, L., ANDREMONT, A., and COUVREUR, P., J. Microencapsulation, 1991, 8, (1), 29–36.
  • Liposome-entrapped ampicillin in the treatment of experimental murine listeriosis and salrnonellosis. FATTAL, E., ROJAS, J., YOUSSEF, M., COUVREUR, P., and ANDREMONT, A., Antimicrob. Agents Chemother., 1991, 35, (4), 770–772.
  • An electron spin resonnce study of merocyanine 540-mediated type I reactions in liposomes. Fix, J. B., and KALYANARAMAN, B., Photochem. Photobiol., 1991, 53, (1), 39–45.
  • Inositol trisphosphate receptor: phosphorylation by protein kinase C and calcium calmodulin-dependent protein kinases in reconstituted lipid vesicles. FERRIS, C. D., HUGANIR, R. L., BREDT, D. S., CAMERON, A. M., and SNYDER, S. H., Proc. Natl. Acad. Sci. USA, 1991, 88, (6), 2232–2235.
  • Transfer of retinol from retinol-binding protein complex to liposomes and across liposomal membranes. FEX, G., JOHANNESSON, G., Methods Enzymol., 1990, 189, 394–402.
  • Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system (ABCD) and a conventional formulation to rats. FIELDING, R. M., SMITH, P. C., WANG, L., PORTER, J., and Guo, L. S. S., Antimicrob. Agents Chemother., 1991,35, (6), 1208–1213.
  • Modulation of tissue plasminogen activator biosynthesis by phosphatidylinositol liposomes in human fetal lung fibroblasts. FLORU, S., GELVAN, A., MARAN, R., KADOURI, A. and COHEN, A. M., Am. J. Hematol., 1991, 36, (2), 100–104.
  • Trypsin entrapped within liposomes. Partition of a low-molecular-mass substrate as the main factor in kinetic control of hydrolysis. FORMELOVA, J., BREIER, A., GEMEINER, P., and KURILLOVA, L., Collect. Czech. Chem. Commun., 1991, 56, (3), 712–717.
  • Intrapulmonary deposition of aerosolized Evans blue dye and liposomes in an experimental porcine model of early ARDS. FORSGREN, P., MODIG, J., GERDIN, B., AXELSSON, B., and DAHLBACK, M., Ups. J. Med. Sc., 1990, 95, (2), 117–136.
  • Adsorption of magnesium(2+), ca1cium(2*), and manganese(V) bilayer vesicles constituted of phosphatidic acid, phosphatidylglycerol and phosphatidylserine. FRAGATA, M., and BELLEMARE, F., Met. Ions Biol. Med., Proc. Int. Symp., 1st, 1990, Libbey, Paris, Fr., pp. 573–575. Ed: P. Collery.
  • Effect of surface-bound lectin on the release of encapsulated sugar from vesicle delivery systems. FRANCIS, S. E., and JONES, M. N., Biochem. Soc. Trans., 1990, 18, (5), 876–877.
  • The effect of surface-bound protein on the permeability of proteoliposomes. FRANCIS, S. E., LYLE, I. G., and JONES, M. N., Biochim. Biophys. Acta, 1991, 1062, (2), 117–122.
  • DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives. FREZARD, F., and GARNIER-SUILLEROT, A., Biochemistry, 1991, 30, (20), 5038–5043.
  • Microscopic localization of liposomes with prolonged circulation in colon carcinoma bearing mice. FRIEND, D. S., HUANG, S. K., HONG, K., and PAPAHADJOPOULOS, D., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (6), A1567.
  • Parameters affecting the immunogenicity of a liposome-associated synthetic hexapeptide antigen. FRISCH, B., MULLER, S., BRIAND, J. P., VAN REGENMORTEL, M. H. V., and SCHUBER, F., Eur. J. Immunol., 1991, 21, (1), 185–193.
  • Effect of alginate-polylysine-alginate microencapsulation on in vitro insulin release from rat pancreatic islets. FRITSCHY, W. M., WOLTERS, G. H., and VAN SCHILFGAARDE, R., Diabetes, 1991, 40, (1), 37–43.
  • Hemolysis mechanism of dental adhesive monomer (methacryloyloxydecyl dihydrogen phospate) using a phosphatidylcholine liposome system as a model for biomembranes. FujtsAwA, S., KADOMA, Y., and KOMODA, Y., Dent. Mater. J., 1990, 9, (2), 136–146.
  • Effect of additives on physical properties of fine ethyl cellulose microcapsules prepared by the Wurster process. FUKUMORI, Y., ICHIKAWA, H., YAMAOKA, Y., AKAHO, E., TAKEUCHI, Y., FUKUDA, T., KANAMORI, R., and OSAKO, Y., Chem. Pharm. Bull., 1991, 39, (1), 164–169.
  • Factors influencing the enhanced hypocalcemic action of liposome-entrapped calcitonin. FUEUNAGA, M., MILLER, M. M., and DEFTOS, L. J., Calcif. Tissue Int., 1990, 47, (6), 373–377.
  • Liposome-entrapped calcitonin and parathyroid hormone are orally effective in rats. FUKUNAGA, M., MILLER, M. M., and DEFTOS, L. J., Horm. Metab. Res., 1991, 23, (4), 166–167.
  • Using polystyrene resins and microcapsulated carbons as sorbents for selective extraction of cholic acid. GALSTYAN, L. R., CHUKHADZHYAN, G. A., MATSOYAN, M. S., SAAKYAN, L. A., and GABRIELYAN, E. S., Eksp. Klin. Med., 1990, 30, (3), 285–288.
  • The use of liposomes, emulsions or inclusion complexes may potentiate in vivo effects of SnET2. GARBO, G. M., Proc. SPIE Int. Soc. opt. Eng., 1990, 1203 (Proc. Photodyn. Ther.: Mech. 2, 1990), 118–125.
  • Universal vaccine carrier. Liposomes that provide T-dependent help to weak antigens. GARCON, N. M., and Six, H. R., J. Immunol., 1991, 146, (11), 3697–3702.
  • Enhancement of in vivo and in vitro T cell response against measles virus hemagglutinin after its incorporation into liposomes: effect of the phospholipid composition. GARNIER, F., FORQUET, F., BERTOLINO, P., and GERLER, D., Vaccine, 1991, 9, (5), 340–345.
  • Lipospheres from microemulsions. GASCO, M. R., and MOREL, S., Farmaco., 1990, 45, (10), 1127–1128.
  • Nanoparticles of poly(isohexyl cyanoacrylate) (PIHCA) as carriers of primaquine: formul-ation, physicochemical characterization and acute toxicity. GASPAR, R., PREAT, V., and ROLAND, M., Int. J. Pharm., 1991, 68, (1-3), 111–119.
  • Assay of methotrexate-gelatin microspheres by pancreatin-ultrasound. GE QINHUA, He WEN and CHEN QINGHUA, Zhongguo Yiyao Gongye Zazhi, 1990, 21, (12), 553–555.
  • The dynamic study of cell surface organization by nanoparticle video microscopy. GEERTS, H., DE-BRABANDER, M., NUYDENS, R., and NUYENS, R., R. J. Cherry (Ed.). Topics in Molecular and Structural Biology: New Techniques of Optical Microscopy and Microspectroscopy. 279 p. CRC Press, Inc.: Boca Raton, Florida, USA, 1991, pp. 119–136.
  • Significance of empty liposomes alone and as drug carriers in dermatotherapy. GEHRING, W., GIIYCZY, M., GLOOR, M., HEITZLER, C., and RODING, J., Arzneimittelforschung, 1990, 40, (12), 1368–1371.
  • beta-Galactosidase fused to the hydrophobic domain of cytochrome 65 spontaneously associates with liposomes. GEORGE, S. K., NAJERA, L., SANDOVAL, R., and IDLER, G. M., Biochim. Biophys. Acta, 1991, 1061, (1), 26–32.
  • Functional characterization and reconstitution in liposomes of a sodium ion: selective transport pathway from pig lens plasma membranes. GIOVANNI, M., ALBERTI, G., and GANDOLFI, S. A., Invest. Ophthalmol. Visual. Sci., 1991, 32, (4), 1204.
  • Effect of liposomes on the skin. GLOOR, M., and GEFIRING, W., Seifen, Oele, Fette, Wachse, 1991, 117, (4), 137–140.
  • The use of angiotensin II as a potential method of targeting cytotoxic microspheres in patients with intrahepatic tumour. GOLDBERG, J. A., MURRAY, T., KERR, D. J., WILLMOTT, N., BESSENT, R. G., McKILLoR, J. H., and MCARDLE, C. S., Br. J. Cancer, 1991, 63, (2), 308–310.
  • The biodegradation of albumin microspheres used for regional chemotherapy in patients with colorectal liver metastases. GOLDBERG, J. A., WILLMOTT, N. S., ANDERSON, J. H., MCCURRACH, G., BESSENT, R. G., McKILLoP, J. H., and MCARDLE, C. S., Nucl. Med. Commun., 1991, 12, (1), 57–63.
  • Modification by diacylglycerols of phospholipid vesicles structure and physical properties. GOMEZ, F. J. C., ARANDA, F. J., VILLALAIN, J., MICOL, V., ORTIZ, A., and HERNANDEZ, T., Prog. Clin. Biol. Res., 1990, 343 (Horiz. Membr. Biotechnol.), 53–67.
  • Fluoroescence studies of changes in methemoglobin structure during interaction with liposomes. GORBENKO, G. P., and DREVAL, V. I., Biofizika, 1990, 35, (6), 925–927.
  • Use of bromthymol blue to study the complex of methemoglobin with liposomes. GoRBENKO, H. P., Ukr. Biokhim. Zh., 1991, 63, (1), 94–98.
  • Liposomes prepared from synthetic amphiphiles. II. Their interaction with Ehrlich ascites tumor cells and tissue distribution in Ehrlich solid tumor-bearing mice. GOTO, R., KuRo, H., DAICHO, Y., and OKADA, S., Chem. Pharm. Bull., 1990, 38, (10), 2805–2809.
  • Effect of reticuloendothelial blockade on tissue distribution of technetium-99m-labeled synthetic liposomes in Ehrlich solid tumor-bearing mice. GOTO, R., KUBO, H., and OKADA, S., Chem. Pharm. Bull., 1991, 39, (1), 230–232.
  • Effect of dilauroylphosphatidylcholine liposomes on motility induction of the acrosome reaction and subsequent egg penetration of ram epididymal sperm. GRAHAM, J. K., NOLAN, J. P., and HAMMERSTEDT, R. H., Biol. Reprod., 1991, 44, (6), 1092–1099.
  • Nanoparticles as carriers for growth hormone releasing factor. GRANGIER, J. L., PUYGRENIER, M., GAUTIER, J. C., and COUVREUR, P., J. Controlled Release, 1991, 15, (I), 3–13.
  • Synthetic peptides corresponding to human follicle-stimulating hormone (hFSH)-beta-(1-15) and hFSH-beta-(5 1-65) induce uptake of 45Ca2* by liposomes: evidence for calcium-conducting transmembrane channel formation. GRASSO, P., SANTA COLOMA, T. A., and REICHERT, L. E. JR., Endocrinology, 1991, 128, (6), 2745–2751.
  • Maelura pomifera agglutinin (MPA) but not lung surfactant secretagogues enhance liposome uptake by rat type H pneumocytes in primary culture. GRIESE, M., and ROONEY, S. A., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (4), A655.
  • Conversion of ammonia or urea into essential amino acids, L-leucine, L-valine,, and L-isoleucine using artificial cells containing an immobilized multienzyme system, and dextran-NAD. L-Lactic dehydrogenase for coenzyme recycling. Gu, K. F., and CHANG, T. M., App. Biochem. Biotechnol., 1990, 26, (2), 115–124.
  • The lung lectin surfactant protein A aggregates phospholipid vesicles via a novel mechanism. HAAGSMAN, H. P., ELFRING, R. H., VAN-BUEL, B. L., and VOORHOUT, W. F., Biochem. J., 1991, 275 (I), 273–276.
  • Liposomes, A new vehicle for therapeutic applications of rhenium-186 and rhenium-188. HAEFELI, U., BLAEUENSTEIN, P., TIEFENAUER, L., and SCHUFHGER, P. A., J. Labelled Compd. Radiopharm., 1991, 30, 333–334.
  • Effects of preparing and ligand-binding methods of small unilamellar liposomes on their blood elimination and tissues distribution in rats. HAGA, M., SAITO, K., ANDO, J., and KATO, Y., Chem. Pharm. Bull., 1990, 38, (10), 2784–2787.
  • Phase behaviour of amphotericin B multilamellar vesicles. HAMILTON, K. S., BARBER, K. R., DAVIS, J. H., NEIL, K., and GRANT, C. W., Biochim. Biophys. Acta, 1991, 1062, (2), 220–226.
  • Arteriovenous shunting is not associated with venous congestion in bone. Knee tamponade studied with 15-microns and 50-microns microspheres in immature dogs. HANSEN, E. S., HJORTDAL, V. E., KJOLSETH, D., HE, S. Z., Hoy, K., SOBALLE, K. and BUNGER, C., Acta Orthop. Scand., 1991, 62, (3), 268–275.
  • Application of lipids to drugs. 7. Application of lipid derivatives to drug delivery systems. HARA, K., Yushi, 1991, 44, (3), 82–87.
  • Characteristics of the binding of asialofetuin-labeled liposomes to isolated rat hepatocytes. HARA, T., ISHIHARA, H., ARAMAKI, Y., and TSUCHIYA, S., Int. J. Pharm., 1991, 67, (2), 123–129.
  • Methodological aspects for free hormone estimation using microencapsulated antibody method-the effect of hormone binding protein on permeability of microcapsule membrane. HASHIMOTO, T., ISHIBASHI, K., and MATSUBARA, F., Ann. Nucl. Med., 1990, 4, (1), 39–42.
  • Preparation of monodisperse polymer microspheres by dispersion polymerization. HATATE, Y., OKAE, T., HIRANO, A., and UMEURA, Y., Kagoshima Daigaku Kogakubu Kenkyu Hokoku, 1990, (32), 85–90.
  • Encapsulation of doxorubicin into liposomes by a freeze-thawing method using buffer solution. HAYAKAWA, E., NAKAKTJRA, M., KATO, Y., OKUBO, Y., and HOSOKAWA, T., Chem. Pharm. Bull., 1991, 39, (3), 773–776.
  • Experience with the liposomal delivery of the photosensitizer isoBoSi Nc. HENDERSON, B. W., and MAYHEW, E., Proc. SPIE Int. Soc. Opt. Eng., 1990, 1203 (Proc. Photodyn. Ther.: Mech. 2, 1990), 126–135.
  • Bovine and rat albumin used as a biodegradable matrix for the slow release of insulin. HERNANDEZ-MONTES, H., VILLALPANDO-HERNANDEZ, S., LOPEZ-AYLLON, R. M., and BOURGUETT-ORTIZ, M., Rev. Invest. Clin., 1990, 42, (4), 265–270.
  • Effects of counteranion of TRH and loading amount on control of TRH release from copoly(d1-lactic/glycolic acid) microspheres prepared by an in-water drying method. HEYA, T., OKADA, H., TANIGAWARA, Y., OGAWA, Y., and TOGUCHI, H., Int. J. Pharm., 1991, 69, (1), 69–75.
  • Encapsulation of enzyme into liposome and requirements for pharmaceutical preparation (size control, powderization and proliposome). HINO, T., NIWA, T., TAKEUCHI, H., and KAWASHIMA, Y Maku, 1990, 15, (6), 321–328.
  • Reconstitution of insect lipophorin apolipophorin II in liposome. HIRAOKA, T., and KATAGIRI, C., ZOO/. Sci. Tokyo, 1990, 7, (6), 1079.
  • Polypeptide spheres. VIII. Polypeptide artificial carrier particles for use in passive agglutin-ation immunoassay. HIRAYAMA, C., IHARA, H., SHIBATA, M., HIRAI, T., FUJIYASU, T., and YAMAUCHI, Y., Polym. J. (Tokyo), 1991, 23, (2), 161–165.
  • Histological findings in rabbit lymph nodes after endolymphatic injection of liposomes containing blue dye. HIRNLE, P., J. Pharm. Pharmacol., 1991, 43, (4), 217–218.
  • Drug depots in lymph nodes: which carrier is most appropriate? HIRNLE, P., J. Mwroencapsul-ation, 1991, 8, (1), 103–119.
  • Relationship of arterial wall uptake of radiolabeled liposomes to the presence of monocyte macrophage cells in the hypertensive and atherosclerotic arterial wall. HODIS, H. N., AMARTEY, J. K., CRAWFORD, D. W., WICKHAM, E., SHARMA, R. C., and BLANKENHORN, D. H., Atherosclerosis, 1991, 87, (2-3), 109–118.
  • Measurement of the bromosulfalein retention in the mouse as a possible parameter for the assessment of liver function after application of liposomal preparations. HOFFMANN, J., FICHTNER, I., BECKER, M., and LEMM, M., Pharmazie, 1991, 46, (3), 222–223.
  • Target-specific binding of immunoliposomes in vivo. HOLMBERG, E., MARUYAMA, K., KENNEL, S., KLIBANOV, A. L., TORCHILIN, V. P., RYAN, U., and HUANG, L., J. Liposome Res., 1990, 1, (4), 393–406.
  • Determination of megestrol acetate and estradiol valerate in injection of microencapsulated compound megestrol acetate by secondary derivative spectrophotometry. HONG ZHENG, Lu BIN and WANG CHAOFAN, Huaxi Yike Daxue Xuebao, 1991, 22, (1), 87–89.
  • Release of human serum albumin from poly(lactide-co-glycolide) microspheres. HORA, M. S., RANA, R. K., NUNBERG, J. H., TICE, T. R., GILLEY, R. M., and HUDSON, M. E., Pharm. Res., 1990, 7,(11), 1190–1194.
  • Use of bromthymol blue to study the complex of methemoglobin with liposomes. HORBENKO, H. P., Ukr. Biokhim. Zh., 1991, 63, (1), 94–98.
  • Pharmacokinetics of polyphase liposome of procamptothecin. Hu CHENGJIU, ZHOU XIAOYAN, Gu XUEQIU and XIA DONGYA, Shenyang Yaoxueyuan Xuebao, 1991, 8, (1), 4–8.
  • Preparation, identification and functional studies on liposome (Apo A-I: PC). Hu, V., Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao, 1990, 12, (6), 396–400.
  • Comparative pharmacokinetics and therapeutics of liposomes with and without G-M-1 ganglioside. HUANG, S. K., MAYHEW, E., GILANI, S., and PAPAHADJOPOULOS, D., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (6), A1566.
  • A new encapsulation system: collagen-glycosaminoglycans-based capsules. Huc, A., BUFFEVANT, C., ANSELME, K., LEVY, M. C., and ANDRY, M. C., Seifen, Oele, Fette, Wachse, 1991, 117, (5), 180–186.
  • Synthesis and characterization of magnetically responsive albumin microspheres containing cis-hydroxyproline for scar inhibition. I ANNOTTI, J. P., BARADET, T. C., TOBIN, M., ALAVI, A., and STAUM, M., J. Orthop. Res., 1991, 9, (3), 432–444.
  • Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia. 'GA, K., HAMAGUCHI, N., IGARI, Y., OGAWA, Y., GOTOH, K., OOTSU, K., TOGUCHI, H., and SHIMAMOTO, T., J. Pharmacol. Exp. Ther., 1991, 257, (3), 1203-1207.
  • Increased tumor cisplatin levels in heated tumors in mice after administration of thermosen-sitive large unilamellar vesicles encapsulating cisplatin. IGA, K., HAMAGUCHI, N., GAR', Y., OGAWA, Y., TooucHI, H., and SHIMAMOTO, T., J. Pharm. Sci., 1991, 80, (6), 522–525.
  • Clinical studies of adriamycin-containing polylactic microspheres administered into the pleural cavity of patients with pleuritis carcinomatosa. IKE, 0., HITOMI, S., WADA, R., WATANABE, S., HYON, S. H., IKADA, Y., and SHimizu, Y., G. Heimke, U. Soltesz and A. J. C. Lee (Eds). Advances in Biomaterials, Vol. 9: Clinical Implant Materials, 676 p. Elsevier Science Publishers B.V., Amsterdam, Netherlands, 1990, pp. 627–632.
  • Treatment of malignant pleural effusions with doxorubicin hydrochloride-containing poly(L-lactic acid) microspheres. IKE, 0., SHIMIZU, Y., HITOMI, S., WADA, R., and IKADA, Y., Chest, 1991, 99, (4), 911–915.
  • Physical properties of polyolefin filled with microencapsulated calcium carbonate. IM SUNG SOON, KIM DONG KOOK and JUNG DEONG YOUNG, Pollimo, 1990, 14, (5), 463–472.
  • Video-enhanced differential interference contrast microscope observation of pH-dependent vesicle formation by single-chain surfactants. ImAE, T., and TREND, B., Langmuir, 1991, 7, (4), 643–646.
  • Liposome-entrapped superoxide dismutase ameliorates infarct volume in focal cerebral ischaemia. Immzum, S., WOOLWORTH, V., KINOUCHI, H., CHEN, S. F., FISHMAN, R. A., and CHAN, P. H., Acta Neurochir. Suppl. (Wien), 1990, 51, 236–238.
  • Reaction mechanism of the reconstituted oxoglutarate carrier from bovine heart mito-chondria. INDIVERI, C., DIERKS, T., KRAMER, R., and PALMIERI, F., Eur. J. Biochem., 1991, 198, (2), 339–347.
  • Effect of dibucaine on the association of protein kinase C with liposome. IRITA, K., Jpn. J. anesthesiol, 1991, 40, (4), 594–598.
  • Specific interaction between water-soluble phospholipid polymer and liposome. ISHIHARA, K., and NAKABAYASHI, N., J. Polym. Sci., Part A: Polym. Chem., 1991, 29, (6), 831–835.
  • Effects of degradable starch microspheres in intra-arterial chemotherapy of liver malig-nancies. Experimental and clinical studies. ITANI, K., Kyoto-furitsu Ika Daigaku Zasshi, 1990, 99, (12), 1417–1432.
  • Synthetic cationic amphiphiles for liposome-mediated DNA transfection. Pro, A., MIYAZOE, R., MITOMA, J., AICAO, T., OSAKI, T., and KUNITAKE, T., Biochem. Int., 1990, 22, (2), 235–241.
  • Behavior of liposomes prepared from lung surfactant analogs and spread at the air-water interface. IVANOVA, T., GEORGIEV, G., PANAIOTOV, I., IVANOVA, M., LAUNOIS-SURPAS, M. A., PROUST, J. E., and PUISIEUX, F., Prog. Colloid Polym. Sci., 1989, 79 (Trends Colloid Interface Sci. 3), 24–32.
  • Beneficial effect of liposome-encapsulated muramyl tripeptide in experimental septicemia in a porcine model. Izsiciu, J. R., RAEDLER, C., ANKE, A., BRUNNER, P., SIEBECK, M., LEINISCH, E., LUETTIKEN, R., RUCKDESCHEL, G., WILKER, D. K. et al., Infect. Immun., 1991, 59, (1), 126–130.
  • Preparation of poly(L-lactide) microspheres of different crystalline morphology and effect of crystalline morphology on drug release rate. IZUMIKAWA, S., YOSHIOKA, S., Aso, Y., and TAKEDA, Y., J. Controlled Release, 1991, 15, (2), 133–140.
  • Evaluation of biodegradable ampicillin anhydrate microcapsules for local treatment of experimental staphylococcal osteomyelitis. JAcoa, E., SETTERSTROM, J. A., BACH, D. E., HEATH, J. R., McN1EsH, L. M., and CIERNY, G., C/m. Orthop., 1991, (267), 237–244.
  • Liposomes as carriers of technetium-99m glucoheptonate for liver imaging. JAGGI, M., KHAR, R. K., CHAUHAN, U. P. S., and GANGAL, S. V., Int. J. Pharm., 1991, 69, (1), 77–79.
  • Preparation and evaluation of ethambutol microspheres. JAIN, G. K., SINGH, S., and SARIN, J. P. S., Indian J. Pharm. Sci., 1990, 52, (3), 153–155.
  • Preparation and evaluation of slow release propranolol hydrochloride microspheres. JAiN, S. K., PANDE, S., and VYAS, S. P., Indian J. Pharm. Sci., 1990, 52, (4), 169–173.
  • Antimicrobial peptides of the magainin family membrane depolarization studies on Escheri-chia coli and cytochrome oxidase liposomes. JURETIC, D., Stud. Biophys., 1990, 138, (1-2), 79–86.
  • Lung uptake of liposome-entrapped glutathione after intratracheal administration. JusimA, R. M., and SHEK, P. N., J. Pharm. Pharmacol., 1991, 43, (1), 6–10.
  • Gadolinium-labeled liposomes containing various amphiphilic gadolinium DTPA deriva-tives: targeted MRI contrast enhancement agents for the liver. KABALKA, G. W., DAVIS, M. A., Moss, T. H., BUONOCORE, E., HUBNER, K., HOLMBERG, E., MARUYAMA, K., and HUANG, L., Magn. Reson. Med., 1991, 19, (2), 406–415.
  • Gadolinium-labeled liposomes containing amphipathic agents for magnetic resonance imaging. KABALKA, G. W., DAVIS, M. A., BUONOCORE, E., HUBNER, K., HOLMBERG, E., and HUANG, L., Invest. Radiol., 1990, 25 (Suppl. 1), S63–S64.
  • Fusion between liposomes and golgi membrane fractions in a cell-free system. KAGIWADA, S., MURATA, M., TAGAYA, M., and OHNISHI, S. I., Cell. Struct. Funct., 1990, 15, (6), 477.
  • Penetration enhancement across a model membrane by liposomally entrapped drugs using N,N'-diacylcystine as a bilayer lipid. KAMAGAMI, S., OKABE, H., KAINOSE, H., KIKKAWA, M., and Ismoami, Y FEBS Lett., 1991, 281, (1-2), 133–136.
  • Comparative evaluation of two membrane-based liposomal MRI contrast agents. KARLIK, S., FLORIO, E., and GRANT, C. W., Magn. Reson. Med., 1991, 19, (1), 56–66.
  • Protection against membrane damage: a 1H-NMR investigation of the effect of Zn' and Ca' on the permeability of phospholipid vesicles. KASZUBA, M., and HUNT, G. R., J. Inorg. Biochem., 1990, 40, (3), 217–225.
  • Amplified determination of metal ions with liposomes incorporating hydrophobic chelating agents. KATAOKA, M., TAKINAMI, M., ABE, H., and UMEZAWA, Y Bunseki Kagaku, 1990, 39, (11), 789–792.
  • Proliposomes of indomethacin for oral administration. KATARE, 0. P., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1991, 8, (1), 1–7.
  • Expression of hepatitis B virus surface antigen in adult rat liver. Co-introduction of DNA and nuclear protein by a simplified liposome method. KATO, K., NAKANISHI, M., KANEDA, Y., UCHIDA, T., and OKADA, Y., J. Biol. Chem., 1991, 266, (6), 3361–3364.
  • Conformational studies of amphipathic alpha-helical peptides containing an animo acid with a long alkyl chain and their anchoring to lipid bilayer liposomes. KATO, T., LEE, S., ONO, S., AGAWA, Y., AOYAGI, H., OHNO, M., and NISHINO, N., Biochim. Biophys. Acta, 1991, 1063, (2), 191–196.
  • Preparation of nicardipine hydrochloride nanosphere and bioavailability in dogs. KATO, Y., SUGIMOTO, Y., INouE, H., MARUYAMA, K., and WAGATSUMA, N., Yakuzaigaku, 1990,50, (3), 225–229.
  • Aplication of fenitrothion microcapsule for insect-proof plywood. KAWASHIMA, M., OHTSUBO, T., TSUDA, S., ITOH, T., and Tsuji, K., Nippon Noyaku Gakkaishi, 1991, 16, (1), 41–46.
  • Characterization of artificial liposomes with free-flow electrophoresis. KESSLER, R., and MANZ, H. J., Electrophoresis, 1990, 11, (11), 979–980.
  • Preparation and characterization of rnonodisperse polymer microspheroids. KEVILLE, K. M., FRANSES, E. I., and CARUTHERS, J. M., J. Colloid Interface Sci., 1991, 144, (1), 103–126.
  • Characterization of L-histidine ammonia-lyase immobilized by microencapsulation in ar-tificial cells: preparation, kinetics, stability, and in vitro depletion of histidine. KHANINA, R., and CHANG, T. M. S., Int. J. Artif. Organs, 1990, 13, (3), 189–195.
  • Microspheres for constant rate delivery systems: an innovative approach. KHARE, D. V., GHORPADE, N. B., and KULKARNI, M. G., Polym. Sci. (Symp. Proc. Polym. '91), Tata McGraw-Hill, New Delhi, India, 1991, pp. 1037–1042. Ed. S. Sivaram.
  • Reaction characteristics and stability of a membrane-bound enzyme reconstituted in bilayers of liposomes. KHEIROLOMOOM, A., KATOH, S., SADA, E., and YOSHIDA, K. I., Biotechnol. Bioeng., 1991, 37, (9), 809–813.
  • Liposomes in diabetes research. KHOLODOVA, E. A., ZABAROVSKAYA, Z. V., and DANILOVA, L. I., Prob.. Endokrinol., 1990, 36, (6), 80–83.
  • Repetitive total fluorescein angiogram using externally triggered liposome-encapsulated fluorescein dye. KHOOBEHI, B., PEYMAN, G. A., and CRUZ, S., Invest. Ophthalmol. Visual Sci., 1991, 32, (4), 866.
  • Clearance of fluorescein incorporated into microspheres from the cornea and aqueous after subconjunctival injection. KHOOBEHI, B., STRADTMANN, M. 0., PEYMAN, G. A., and ALv, 0. M., Ophthalmic Surg., 1990, 21, (12), 840–844.
  • Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection. KHOOBEHI, B., STRADTMANN, M. 0., PEYMAN, G. A., and ALY, 0. M., Ophthalmic Surg., 1991, 22, (3), 175–180.
  • Study of the biological activity of vitamin D-3 in liposomes. KHRESTOVAYA, N. L., APUKHOVSKAYA, L. I., and GURINA, N. M., Khim. Farm. Zh., 1990, 24, (11), 52–55.
  • Interaction of poly(L-lysine-alt-terephthalic acid) microcapsules with fibrinogen. KIDOKORO, M., OHSHIMA, H., and KONDO, T., J. Microencapsulation, 1991, 8, (1), 63–70.
  • Preparation of sustained-release microspheres of phenylpropanolamine hydrochloride and their release characteristics. KIM, C. K., LEE, K. M., HWANG, S. J., and YOON, Y. S., Arch. Pharmacol. Res., 1990, 13, (4), 293–297.
  • Pharmacokinetics of intravitreally injected liposome-encapsulated tobramycin in normal rabbits. KIM, E. K., and KIM, H. B., Yonsei Med. J., 1990, 31, (4), 308–314.
  • Delivery of phytochrome into plant protoplasts by liposomes. Kim, I. S., Lim, M. H., and SONG, P. S., Korean Biochem. J., 1991, 24, (2), 103–110.
  • Interactive effect of hydrogen sulfide production from cysteine and methanethiol production from methionine in milk-fat-coated microcapsules containing Brevibacterium linens. Kim, S. C., Kim, M., and OLsoN, N. F., J. Dairy Res., 1990, 57, (4), 579–585.
  • Injectable microspheres with controlled drug release for glaucoma filtering surgery. KIMURA, H., MORITERA, T., OGURA, Y., HONDA, Y WADA, R., HYON, S. H., and IKADA, Y., Invest. Ophthalmol. Visual Sci., 1991, 32, (4), 745.
  • Rotational diffusion of cytochrome P-450 in the presence of NADPH-cytochrome P-450 reductase in liposomes of different phospholipid composition. KISELEY, P. A., GARDA, G., FINCH, S. A. E., STIR, A., GURINOVICH, N. A., KHAMYLEVA, S. Yu, and AKHREM, A. A., Biol. Membr., 1990, 7, (10), 1026–1036.
  • A measurement of complement activity using immunoliposome. KISHIMURA, M., YAmAji, H., FUKUDA, H., TERASHIMA, M., KATOH, S., SADA, E., and TANIGUCHI, H., Ann. N.Y. Acad. Sc., 1990, 613, 405–409.
  • Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of osteosarcoma. KLEINERMAN, E. S., and JAFFE, N., Cancer Bul., 1991, 43, (2), 127–132.
  • Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. KLIBANOV, A. L., MARUYAMA, K., BECKERLEG, A. M., TORCHILIN, V. P., and HUANG, L., Biochint. Biophys. Acta, 1991, 1062, (2), 142–148.
  • Microcapsules. Their applications to pharmaceutical techniques. KOKUFUTA, E., Fragrance J., 1991, 19, (3), 16–21.
  • Chemoembolization with degradable starch microspheres for liver metastases of colorectal cancer. KONDO, M., ITANI, K., YOSHIKAWA, T., °YAMADA, H., ICHIKAWA, H., KOKURA, S., TAINAKA, K., and SUGINO, S., Gan To Kagaku Ryoho, 1991, 18, (4), 535–540.
  • Characteristics of microcapsules as viewed from a standpoint of membrane science. KONDO, T., Pharm. Tech. Jpn., 1991, 7, (3), 263–269.
  • IL-2 conjugated liposomes: a drug delivery system for the IL-2 R positive cells. KONIGSBERG, P. J., and GODTEL, R. R., J. Cell Biochem. Suppl., 1991, (15, Part F), 74.
  • Inhibition of growth of rat hepatoma by local injection of liposomes containing recombinant interleukin-2: antitumor effect of IL-2 liposome. KONNO, H., YAMASHITA, A., TADAKUMA, T., and SAKAGUCHI, S., Biotherapy, 1991, 3, (3), 211–218.
  • Phagocytosis of beta-1,3-D-glucan-derivatized microbeads by mouse peritoneal macrophages involves three different receptors. KONOPSKI, Z., RASMUSSEN, L. T., SELJELID, R., and ESKELAND, T., Scand. J. Immunol., 1991, 33, (3), 297–306.
  • Reconstruction of genetic system of maize mitochondria in liposomes during gel-filtration on Sephadex LH-20. KONSTANTINOV, Yu. M., LUTSENKO, G. N., PODSOSONNYI, V. A., KHAPTAGAEV, S. B., KOPYTCHUK, V. N., and SALYAEV, R. K., Biol. Membr., 1990, 7, (12), 1295–1301.
  • Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. KORTING, H. C., ZIENICKE, H., SCIIAFER-KORTING, M., and BRAUN-FALCO, 0., Eur. J. Clin. Pharmacol., 1990, 39, (4), 349–351.
  • Interactions of ferrous ions with peroxidized lecithin-liposomes. KOWALSKA, E., and NAGLIK, T., Acta Biochim. Pol., 1990, 37, (1), 85–88.
  • Xenotransplantation of microencapsulated fetal rat islets. KRESTOW, M., Lum, Z. P., TAI, I. T., and SUN, A., Transplantation, 1991, 51, (3), 651–655.
  • Large-scale production problems and manufacturing of nanoparticles. KREUTER, J., P. Tyle (Ed.), Drugs and the Pharmaceutical Sciences, Vol. 41. Specialized Drug Delivery Systems: Manufacturing and Production Technology. 475 p. Marcel Dekker, Inc., New York, N.Y., USA; 1990, pp. 257–266.
  • Disposition of lyophilized (methylmethacrylate-14C, 2-hydroxyethylmethacrylate, butylacry-late) nanoparticles in rats and their effect on zoxazolamine paralysis time. KUKAN, M., KOPRDA, V., BEZEK, S., KALAL, J., LARSKY, J., and TRNOVEC, T., Pharmazie,1991, 4.6,(1), 37–39.
  • Saturable, non-Michaelis-Menten uptake of liposomes by the reticuloendothelial system. KUME, Y., MAEDA, F., HARASHIMA, H., and KIWADA, H., J. Pharm. Pharmacol., 1991, 43, (3), 162–166.
  • Binding of alpha- and beta gamma-subunits of Go to beta 1-adrenoceptor in sealed unilamellar lipid vesicles. KURSTJENS, N. P., FROHLICH, M., DEES, C., CANTRILL, R. C., HEKMAN, M., and HELMREICH, E. J., Eur. J. Biochem., 1991, 197, (1), 167–176.
  • Production of 5-150 diameter alginate-polylysine microcapsules by an air-atomization technique. KWOK, K. K., GROVES, M. J., and BURGESS, D. J., Pharm. Res., 1991,8, (3), 341–344.
  • Mathematical modeling of protein diffusion in microcapsules: a comparison with experi-mental results. KWOK, W .Y KIPARISSIDES, C., YUET, P., HARRIS, T. J., and GOOSEN, M. F. A., Can. J. Chem. Eng., 1991, 69, (1), 361–370.
  • Preparation and characterization of microspheres of albumin-heparin conjugates. KWON, G. S., BAE, Y. H., KIM, S. W., CREMERS, H., and FEIJEN, J., J. Colloid Interface Sci., 1991, 143,(2), 501–512.
  • A study of the zeta potential of microcapsules during aging. LABHASETWAR, V. D., and DORLE, A. K., J. Microencapsulation, 1991, 8, (1), 83–85.
  • Study of shellac-glycerol esters as microencapsulating materials. II. Quantitative correlation between physicochemical properties and release characteristics. LABHASETWAR, V. D., PURANIK, P. K., and DORLE, A. K., J. Microencapsulation, 1990, 7, (4), 553–554.
  • Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa. LAGACE, J., DUBREUIL, M., and MONTPLAISIR, S., J. Microencapsulation, 1991, 8, (1), 53–61.
  • Movement of fluorescent microspheres along lobar margins in the pleural space due to cardiogenic motion. LA I- FOOK, S. J., and WANG, P. M., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (4), A747.
  • Drug targeting using non-magnetic and magnetic albumin-globulin mix microspheres of mefenamic acid. LALLA, J. K., and AnujA, P. L., J. Microencapsulation, 1991, 8, (1), 37–52.
  • Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghost membranes: effects of lipid composition, pH and calcium. LARSEN, C. E., ALFORD, D. R., YOUNG, L. J. T., McGRAw, T. P., and DUZGUNES, N., J. Gen. Virol., 1991, 72, (2), 473.
  • Creon enteric coated pancreatin microspheres for the treatment of pain in chronic pancrea-titis: a double blind randomized placebo controlled crossover study. LARVIN, M., MCMAHON, M. J., THOMAS, W. E.G., and PUNTIS, M. C. A., Gastroenterology, 1991, l00,(5, Part 2), A283.
  • Kinetic and thermodynamic effect on the structure and formation of phosphatidylcholine vesicles (letter). LASIC, D. D., Hepatology, 1991, 13, (5), 1010–1012.
  • Phase I trial of the combination of gamma-interferon (IFN) and liposomal MTP-PE (L-mtppe) in patients with disseminated cancer. LAUTERSZTAIN, J., KLEINERMAN, J. E., FIDLER, J., BENJAMIN, R. S., KRAKOFF, I., and GUTTERMAN, J. U., PrOC. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 202.
  • Mechanism of the transmembrane potential effect on the charge photoseparation in lipo-somes. LAVRENT'EVA, A. I., NADTOCHENKO, V. A., RUBTSOV, I. V., DENISOV, N. N., BARANNIKOVA, YA. V., and NIKANDROV, V. V., Biol. Membr., 1990, 7, (9), 966–977.
  • Characteristics of mitoxantrone loading on liposomes. LAW, S. L., CHANG, P., and LIN, C. H., Int. J. Pharm., 1991, 70, (1–2), 1–7.
  • The solubilization behavior of DOPE-immunoliposomes with immunoglobulin G(IgG) by added bile salts. LEE-EuN-Ox, KIM-JIN-GU and KIM-JoNG-DuK, Yakche Hakhoechi, 1990, 20, (3), 135–144.
  • Simplified method of making alginate-polylysine microcapsules for hybridoma cell culture using RPMI 1640 medium. LEE, G. M., and PALSSON, B. 0., Biotechnol. Tech., 1990,4, (5), 341–344.
  • Preparation and dissolution properties of ftorafur-gelatin microcapsules. LEE-SU-JUNG and Yakche Hakhoechi, 1990, 20, (3), 129–134.
  • A simple method for estimation of phospholipids in biological objects. LEMESHKO, V. V., BROVKOVICH, V. M., and LISTOPAD, A. P., Ukr. Biokhim. Zh., 1991, 63, (1), 60–66.
  • Size analysis and stability study of lipid vesicles by high-performance gel exclusion chromatography, turbidity, and dynamic light scattering. LESIECR, S., GRABIELLE MADELMONT, C., PATERNOSTRE, M. T., and OLLIvorv, M., Anal. Bi °chem., 1991, 192, (2), 334–343.
  • Cardiopulmonary toxicity after liposomal amphotericin B infusion. LEVINE, S. J., WALSH, T. J., MARTINEZ, A., EICHACKER, P. Q., LOPEZ BERESTEIN, G., and NATANSON, C., Ann. Intern. Med., 1991, 114, (8), 664–666.
  • Polyhydroxamic serum albumin microcapsules: preparation and chelating properties. LEVY, M. C., HETTLER, D., ANDRY, NI. C., and RAMBOURG, P., Int. J. Pharm., 1991, 69, (1), R1–R4.
  • Fourier transform ir spectroscopic studies of human serum albumin microcapsules prepared by interfacial cross-linking with terephthaloylchloride: influence of polycondensation pH on spectra and relation with microcapsule morphology and size. LEVY, M. C., LEFEBVRE, S., RAHMOUNT, M., ANDRY, M. C., and MANFAIT, M., J Pharm. Sci., 1991,80, (6), 578–585.
  • A compatison of transcranial Doppler ultrasound (TCD) and radioactive microspheres in determining cerebral perfusion in normal and low flow states. LEWIS, L. M., STOTHERT, J. C. JR., KRAUS, G. E., GOMEZ, C. R., GOODGOLD, H., KELTNER, R. M. JR., ASHLEY, K., and FORTNEY, J. P., Resuscitation, 1990, 20, (3), 213–220.
  • Functional polymer microspheres. Emulsifier-free emulsion copolymerization of styrene with sodium styrenesulfonate microspheres. Lt XIONGWEIR, VAN CHANGHONG, ZHOU CHENDE and SUN ZONGHUA, Gongneng Gaofenzi Xuebao, 1989, 2, (4), 267–274.
  • Polyethyleneglycol-induced fusion between mitochondrial inner membrane and liposomes.
  • Liu LIN and LIN QISHUI, Shengwu Huaxue Yu Shengwu Wuli Xuebao, 1990, 22, (4), 377–383. Reconstitution of choline dehydrogenase in liposomes. Liu Lix and LIN QisHul, Shengwu Huaxue
  • Zazhi, 1990, 6, (6), 527–532.
  • Structural properties of vesicles produced from a new bipolar lipid. Lo NOSTRO, P., BRIGANTI, G., and CHEN, S. H., J. Colloid Interface Sci., 1991, 142, (1), 214–223.
  • Antitumor effects of interleukin 2 liposomes and anti-CD3-stimulated T-cells against murine MCA-38 hepatic metastasis. LOEFFLER, C. M., PLATT, J. L., ANDERSON, P. M., KATSANIS, E., OCHOA, J. B., URBA, W. J., LONGO, D. I., LEONARD, A. S., and OCHOA, A. C., Cancer Res., 1991,51, (8), 2127–2132.
  • Effect of ultrasound on the encapsulation of titanium dioxide pigment. LORIMER, J. P., MASON, T. J., KERSHAW, D., LIVSEY, I., and TEMPLETON-KNIGHT, R., Colloid Polym. Sci., 1991, 269, (4), 392–397.
  • Liposome chromatography: liposomes immobilized in gel beads as a stationary phase for aqueous column chromatography. LUNDAHL, P., and YANG, Q., J. Chromatogr., 1991, 544, (1-2), 283–304.
  • Partitioning of an homologous series of alkyl p-aminobenzoates into multilamellar liposomes: effect of liposome composition. MA, L., RAMACHANDRAN, C., and WEINER, N. D., Int. J. Pharm., 1991, 70, (3), 209–218.
  • Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. MACDONALD, R. C., MACDONALD, R. I., MENCO, B. P., TAKESHITA, K., SUBBARAO, N. K., and Hu, L. R., Biochim. Biophys. Acta, 1991, 1061, (2), 297–303.
  • Vectorized liposomes as DNA transfer agents. MACHY, P., and LESERMAN, L., B. Malissen, Techniques en Immunologie: Transfert et Expression de Genes Dans les Cellules de Mammiferes; (Techniques in Immunology: Gene Transfer and Expression in Mammalian Cells). 84p. Editions INSERM: Paris, France, 1990, pp. 49–68.
  • Endocytosis of cell surface molecules and intracellular delivery of materials encapsulated in targeted liposomes. MACHY, P., and LESERMAN, L., NATO ASI Ser., Ser. A, 1990, 199 (Targeting Drugs 2), 77–86.
  • Signal-sensitive release of content from liposomes bearing surface-grafted polyelectrolyte chains. MAEDA, M., KUMANO, A., and TIRRELL, D. A., Ann. N.Y. Acad. Sci., 1991, 618, 362–366. Unusual product ratios resulting from the gamma-irradiation of cholesterol in liposomes.
  • MAERKER, G., and JONES, K. C., Lipids, 1991, 26, (2), 139–144.
  • Current aspect of research and development of liposome. MAITANI, Y., and NAGAI, T., Fragrance J., 1991, 19, (3), 28–32.
  • Localization of administered liposomal human sod and porcine sod in the abdominal aorta of rats. MAKITA, T., ISHIDA, T., KAWATA, M., and LINDBLOM, R., Acta Histochem Cytochem., 1990, 23, (5), 715.
  • Interactions of human platelets with liposomes and Sendai virus. MALE, R., VANNIER, W., and BALDESCHWIELER, I. D., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (4), A523.
  • Therapy of human ovarian cancer xenografts with intraperitoneal liposome encapsulated muramyl-tripeptide phosphoethanolamine (MTP-PE) and recombinant GM-CSF. MALIK, S. T., MARTIN, D., HART, I., and BALxwiLL, F., Br. J. Cancer, 1991, 63, (3), 399–403.
  • The effect of eswl on microspheres in fluids of varying viscosity. MANNE, J. S., ORYTE, C. C., and SMITH, A. D., J. Urol., 1991, 145 (4, Suppl), 254A.
  • Value of the new drug carriers in ophthalmology: liposomes and nanoparticles. MARCHAL HEUSSLER, I., MAINCENT, P., HOFFMAN, M., and SIRBAT, D., J. Fr. Ophtalmol.,1990, 13, (11-12), 575–582.
  • Poly(chloromethylstyene) microspheres: synthesis and characterization. MARCEL, S., Nov, E., and FISHER, I., J. Polym. Sci., Part A: Polym. Chem., 1991, 29, (3), 347–355.
  • Pharmaceutical manufacturing of liposomes. MARTIN, F. J., P. Tyle (Ed.), Drugs and the Pharmceutical Sciences, Vol. 41: Specialized Drug Delivery Systems: Manufacturing and Production Technology, 475 p. Marcel Dekker, Inc., New York, N.Y., USA, 1990, pp. 267–316.
  • Functional reconstitution of the malate carrier of barley mesophyll vacuoles in liposomes. MARTINOIA, E., VOGT, E., RENTSCH, D., and AMRHEIN, N., Biochim. Biophys. Acta, 1991, 1062, (2), 271–278.
  • Characterization of in vivo immunoliposome targeting to pulmonary endothelium. MARUYAMA, K., HOLMBERG, E., KENNEL, S. J., KLIBANOV, A., TORCHILIN, V. P., and HUANG, L., J. Pharm. Sci., 1990, 79, (11), 978–984.
  • Characterization of small lipid vesicles prepared by microfluidization. MASSON, G., Prog. Colloid Polym. Sci., 1989, 79 (Trends Colloid Interface Sci. 3), 49–51.
  • The current status of and outlook for the use of suspensions of magnetic particles in oncology. MAVRICHEV, A. S., and FERTMAN, V. E., Vopr. Onkol., 1991, 37, (1), 11–17.
  • Free and liposomal doxorubicin treatment of intraperitoneal colon 26 tumor: therapeutic and pharmacologic studies. MAYHEW, E., CIMINO, M., KLEMPERER, J., LAZO, R., WIERNIKOWSKI, J., and ARBUCK, S., Sel. Cancer Ther., 1990, 6, (4), 193–209.
  • Liposomes, erythrocytes, and other macromolecule-targeted drug-delivery systems. MAYHEW, E.,, and FREEMAN, A. I., S. G. Economou, T. R. Witt, D. J. Deziel, T. J. Saclarides, E. D. Staren and S. D. Bines (Eds), Adjuncts to Cancer Surgery. 703 p. Lea and Febiger, Philadelphia, Pennsylvania, USA, 1991, pp. 423–428.
  • Effects of treatment with microencapsulated monosialoganglioside GM1 on cortical and striatal acetylcholine release in rats with cortical devascularizing lesions. MAYSINGER, D., HERRERA MARSCHITZ, M., UNGERSTEDT, U., and CUELLO, A. C., Neurosci. Lett., 1990, 118, (2), 252–256.
  • Formation of polymeric microspheres using electron beam radiation. MCHERRON, D. C., and WILKES, G. L., Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.), 1990, 31, (2), 367–368.
  • Targeting of plant glycoside-bearing liposomes to specific cellular and subcellular sites. MEDDA, S., DAS, N., BACHHAWAT, B. K., MAHATO, S. B., and BASU, M. K., Biotechnol. Appl. Biochem., 1990, 12, (5), 537–543.
  • The effect of site of administration in the gastrointestinal tract on the absorption of insulin from nanocapsules in diabetic rats. MICHEL, C., APRAHAMIAN, M., DEFONTAINE, L., COUVREUR, P., and DAMGE, C., J. Pharm. Pharmacol., 1991, 43, (1), 1–5.
  • Interaction of polymer microspheres with mucin gels as a means of characterizing polymer retention on mucus. MIKOS, A. G., MATHIOWITZ, E., LANGER, R., and PEPPAS, N. A., J. Colloid Interface Sci., 1991, 143, (2), 366–373.
  • Interaction of solid and liquid crystalline multilamellar liposomes with alveolar macro-phages. MINCHEVA, R., BOYANOV, A., and TENCHOV, B., C.R. Acad. Bulg. Sci., 1990,43, (12), 99–100.
  • Calcium and magnesium induced changes in the relative fluidity of phosphatidylcholine liposomes. MISHRA, R. K., and SINGHAL GAURI, S., J. Biosci., 1990, 15, (3), 193-197. Development of microspheres for diagnosis. MITANI, K., FDA, Y., and MAEHARA, T., Kagaku
  • Kogyo, 1990, 41, (4), 316–324.
  • Reconstitution of the L-leucine-H* contransporter of the plasma membrane from Chang liver cells into proteoliposomes. MITSUMOTO, Y., and MOHRI, T., Biochim. Biophys. Acta, 1991, 1061, (2), 171–174.
  • Induction of chromosomal aberrations by restriction endonucleases encapsulated in lipo-somes. MIXICH, F., Mutat. Res., 1991, 262, (3), 177–181.
  • Growth inhibition of glioma cells of different cell lines by human interferon-beta produced in the cells transfected with its gene by means of liposomes. MIZUNO, M., YOSFIIDA, J., SUGITA, K., and YAGI, K., J. Clin. Biochem. Nutr., 1990, 9, (2), 73–78.
  • Distribution of lipid microspheres incorporating prostaglandin El to vascular lesions. MIZUSHIM k, Y., HAMAN°, T., HARAMOTO, S., KIYOKAWA, S., YANAGAWA, A., NAKURA, K., SHINTOME, M., and WATANABE, M., Prostaglandins Leukot. Essent. Fatty Acids, 1990,41, (4), 269–272.
  • Large-scale use of hollow fiber and microencapsulated pink bollworm pheromone formul-ations integrated with conventional insecticides for the control of the cotton pest complex in Egypt. MOAWAD, G., KHIDR, A. A., ZAKI, M., CRITCHLY, B. R., MCVEIGH, L. J., and CAMPION, D. G., Trop. Pest. Manage., 1991, 37, (1), 10–16.
  • Physiopathological and physicochemical considerations in targeting of colloids and drug carriers to the bone marrow. Moommi, S. M., ILLum, L., and DAVIS, S. S., Grit. Rev. Ther. Drug Carrier Syst., 1990, 7, (3), 187–209.
  • Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. MocHimi, S. M., PORTER, C. J., MUIR, I. S., ILLum, L., and DAVIS, S. S., Biochem. Biophys. Res. Commun., 1991, 177, (2), 861–866.
  • The effect of Poloxamer 407 on liposome stability and targeting to bone marrow: comparison with polystyrene microspheres. MOGHIMI, S. M., PORTER, C. J. H., ILLum, L., and DAVIS, S. S., Int. J. Pharm., 1991, 68, (1-3), 121–126.
  • Differential influence of anionic and cationic charge on the ability of amphiphilic drugs to interact with DPPC-liposomes. MOHR, K., and STRUVE, M., Biochem. Pharmacol., 1991, 41, (6-7), 961–965.
  • Growth inhibition of Plasmodium fakiparum in in vitro cultures by selective action of tryptophan-N-formylated gramicidin incorporated in lipid vesicles. MOLL, G. N., VAN DEN EERTWEGH, V., TOURNOIS, H., ROELOFSEN, B., OP DEN RAMP, J. A., and VAN DEENEN, L. L., Biochim. Biophys. Acta, 1991, 1062, (2), 206–210.
  • Activity and distribution of urease following microencapsulation within polyamide membranes. MONSFHPOURI, M., and NEUFELD, R. J., Enzyme Microb. Technol., 1991, 13, (4), 309–313. Heats of formation of polyphosphate coacervates as functions of their composition. MONTAGNE, L., PALAVIT, G., VAST, P., and MORCELLET, M., Calorim. Anal. Therm., 1990, 20–21. 235–241.
  • Polyacrylic microspheres as a solid phase for microparticle enhanced nephelometric immunoassay (NEPHELIA (R)) of transferrin. MONTAGNE, P. LAROCHE, P., CUILLIERE, M. L., RIOCHET, D., FLECHEUX, 0., VARCIN, P., MARCHAND, J., PAU, B., and DUHEILLE, J., J. Immunoassay, 1991, 12, (2), 165–183.
  • Purification and partial characterization of extracellular liposomes isolated from the hyper-lipidemic rabbit aorta. MORA, R., SIM IONESCU, M., and SIM IONESCU, N., J . Lipid Res., 1990, 31, (10), 1793–1807.
  • Applications of fluorescent liposomes. MORGAN, J., Appl. Fluoresc. Technol., 1990, 2, (1), 14-16. Effect of arterial infusion of microspheres on the formation of gastric ulcer. MORISHITA, T., NAGATA, H., SUZUKI, M., SUEMATSU, M., HOUZAWA, S., SAWAGUCHI, K., SEKIZUKA, E., MIURA, S., OSHIO, C. et al., Gastroenterology, 1991, 100 (5, Part 2), A128.
  • Targeting of drugs to the retinal pigment epithelium by surface-modified polymer micro-spheres. MORITERA, T., OGURA, Y., YOSHIMURA, N., KURIYAMA, S., NAKANO, T., HONDA, Y., TABATA, Y., and IKADA, Y., Invest. Ophthalmol. Visual Sci., 1991, 32, (4), 1294.
  • Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. MORITERA, T., OGURA, Y., HONDA, Y., WADA, R., HYON, S. H., and IKADA, Y., Invest. Ophthalmol. Visual Sci., 1991, 32, (6), 1785–1790.
  • Dynamics of liposomes constructed from phytanyl lipids. Moss, R. A., and FuJITA, T., Tetrahedron Lett., 1990, 31, (52), 7559–7562.
  • Propidium iodide-loaded poly(alkyl cyanoacrylate) particles-labeling conditions and load capacity. MUELLER, R. H., LHERM, C., HERBORT, J., and COUVREUR, P., Colloid Polym. Sci., 1991, 269, (2), 147–152.
  • Adsorption of negatively charged microcapsules to a poly-2-hydroxyethylmethacrylate polyamine graft co-polymer surface. MURAMATSU, N., YOSHIDA, Y., KATAYAMA, Y OHSHIMA, H., and RONDO, T., J. Biomater. Sci. Polym. Ed., 1991, 2, (2), 139–146.
  • Possible application of polyamine graft copolymer to targeting drug delivery. MURAMATSU, N., YOSHIDA, Y., and KONDO, T., Chem. Pharm. Bull., 1990, 38, (11), 3175–3176.
  • Studies on biodegradable microcapsules of anticancer drugs. MURATA, K., NAKAMURA, K., TSUBAKIMOTO, M., NAKATSUKA, H., MINAKUCHI, K., OHOYAMA, Y., KANAMORI, R., and FUKUMORI, Y., Nippon Igaku Hoshasen Gakkai Zasshi, 1991, 51, (1), 94–90.
  • Bioavailability of theophylline from microencapsulated formulations. MURAVEV, I. A., MAKAROV, V. A., and ANDREEVA, I. N., Farmatsiya (Moscow), 1991, 40, (1), 36-38. Observation of toroidal vesicles. MUTZ, M., and BENSIMON, D., Phys. Rev. A., 1991, 43, (8), 4525–4527.
  • Liposomes as carriers for antibiotics. NACUCCHIO, M. C., Di Rocco, P. H., and SORDELLI, D. 0., P. Tyle and B. P. Ram (Ed.). Targeted Diagnosis and Therapy Series, Vol. 3. Targeted Therapeutic Systems. 388 p. Marcel Dekker, Inc.: Monticello, N.Y., USA, 1990, pp. 337–354.
  • Effect of transmembrane potential on charge photoseparation in liposomes. NADTOCHENKO, V. A., LAVFIENT'EV, A. I., RUBTSOV, I. V., DENISOV, N. N., BARANNIKOVA, Y. V., NIKANDROV, V. V., and KRASNOVSKII, A. A., Photochern. Photobiol., 1991, 53, (2), 261–269.
  • Recombination kinetics of pheophytin a radicals, and ascorbate in liposome suspensions. NADTOCHENKO, V. A., and RUBTSOV, I. V., Zh. Fiz. Khim., 1991, 65, (4), 1057–1063.
  • In vitro induction of primary cytotoxic responses by dendritic cells using ovalbumin encapsulated in pH-sensitive liposomes. NAIR, S., ZHOU, F., REDDY, R., HUANG, L., and ROUSE, B. T., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (5), A974.
  • Influence of timing of administration of liposome-encapsulated superoxide dismutase on its prevention of acetaminophen-induced liver cell necrosis in rats. NAKAE, D., YosHiji, H., YAMAMOTO, K., MARUYAMA, H., KINUGASA, T., TAKASHIMA, Y DENDA, A., and KoNism, Y Acta Pathol. Jpn., 1990, 40, (8), 568–573.
  • Effect of liposome-encapsulated recombinant human superoxide dismutase (liposome-r-h-SOD) on the lung injury induced by Forssman antiserum in guinea pigs. NAKAGAMI, K., INAMURA, M., NAKANO, Y., and KOBAYASHI, Y Nippon Yakurigaku Zasshi, 1991, 97, (1), 41–49.
  • Repeated injections of rabbit anti-sheep platelet antibody diminish phagocytosis of liposomes by pulmonary intravascular macrophages in sheep. NAKANO, T., MIYAMOTO, K., AIDA, A., Am, K., and KAWAKAMI, Y., Am. Rev. Respir. Dis., 1991, 143, (4, Part 2), A376.
  • Monensin-mediated antiport of sodium and hydrogen ion across the liposome membrane. NAKAZATO, K., and HATANO, Y Biochim. Biophys. Acta, 1991, 1064, (1), 103–110.
  • Liposomes. NASSENDER, U. K., STORM, G., PEETERS, P. A. M., and CROMMELIN, D. J. A., M. Chasin and R. Langer (Eds). Drugs and the Pharmaceutical Sciences, Vol. 45. Biodegradable Polymers as Drug Delivery Systems. 347 p. Marcel Dekker, Inc., New York, N.Y., USA, 1990, pp. 261–338.
  • In vitro release profile of mitomycin C from albumin microspheres; extrapolation from macrospheres to microspheres. NATSUME, H., SUGIBAYASHI, K., and MORIMOTO, Y Pharm. Res., 1991, 8, (2), 185–190.
  • Biotechnology frontier: targeted drug delivery. NEWTON, D. W., US Pharm., 1991, 16, (6), 38–39. 43–44. 46–48. 50.
  • Coacervation: principles and applications. NEWTON, D. W., Polym. Controlled Drug Delivery, CRC, Boca Raton, Fla., USA, 1991, pp. 67–81. Ed. P. J. Tarcha.
  • The effect of blood on the uptake of liposomal lipid by perfused rat liver. NICHOLAS, A. R., and JONES, M. N., Biochim. Biophys. Acta, 1991, 1074, (1), 105–111.
  • A fluorescence assay of liposome uptake by human retinal pigment epithelial cells (RPE).
  • NIESMAN, M. R., and PEYMAN, G. A., Invest. Ophthalmol. Visual Sci., 1991, 32, (4), 882. Cytotoxic potential of liposomes containing tumor necrosis factor-alpha against sensitive and resistant target cells. No, A., FAN, D., and FIDLER, I. J., J. Immunother., 1991, 10, (1), 13–19. Influence of microencapsulation conditions on physicotechnological properties of microcapsules. NIKOLAEV, A. S., Farmatsiya (Mosc.), 1990, 39, (5), 31–35.
  • Manufacture, and analysis of acetylsalicylic acid microcapsules. NIKOLAEV, A. S., and BARDAKOV, A. I., Farmcasiya (Moscow), 1991, (2), 20–23.
  • Fusion of enveloped viruses with cells and liposomes. Activity and inactivation. NIB, S., DUZGUNES, N., DE LIMA, M. C., and HOEKSTRA, D., Cell Biophys., 1990, 17, (2), 181–201.
  • Release characteristics of cisplatin chitosan microspheres and effect of containing chitin. NISHIOKA, Y., KYOTANI, S., OKAMURA, M., MIYAZAKI, M., OKAZAKI, K., OHNISHI, S., YAMAMOTO, Y., and ITO, K., Chem. Pharm. Bull., 1990, 38, (10), 2871–2875.
  • Nebulization of liposomes. I. Effects of lipid composition. NIVEN, R. W., and SCHREIER, H., Pharm. Res., 1990,7, (11), 1127–1133.
  • Nebulization of liposomes. IL The effects of size, and modeling of solute release profiles. NIVEN, R. W., SPEER, M., and SCHREIER, H., Pharm. Res., 1991, 8, (2), 217–221.
  • Priming for in vitro and in vivo anti-human T lymphotropic virus type 1 cellular immunity by virus-related protein reconstituted into liposome. Nocucm, Y., NocticHi, T., SATO, T., YOKO°, Y., Fron, S., YOSHIDA, M., YOSHIKI, T., AKIYOSHI, K., SUNAMOTO, J., NAKAYAMA, E. et al., J. Immunol., 1991, 146, (10), 3599–3603.
  • Proton permeability of cytochrome oxidase-containing proteoliposomes. NORRIS, F. A., ABRAMOVITCH, D. A., and POWELL, G. L., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (5), A1191.
  • Synthesis and application of thermosensitive microcapsules containing azo groups. NUYKEN, 0., DAUTH, J., and PEKRUHN, W Angew. Makromol. Chem., 1991, 187, 207–224.
  • Dietary fiber, fat and beef modulation of colonic nuclear aberrations and microcapsule-trapped gastrointestinal metabolites of benzo(a) pyrene-treated C57/B6 mice consuming human diets. O'NEILL, I. K., GOLDBERG, M. T., GHISSASSI, F. EL., and Row, M. M., Carcinogenesis, 1991, 12, (2), 175–180.
  • Analysis of the molecular requirements for T cell recognition and activation by using Ia-containing lipid vesicles and stopped-flow fluorometry. ODAKA, C., UTSUNOMIYA, N., NAKANISHI, M., ARATA, Y., MANABE, S., YASUDA, T., and TADAKUMA, T., Int. Immunol., 1990, 2, (6), 509–514.
  • Effect of dextran sulfate on fusion of Sendai virus with human erythrocyte ghosts. Omu, S., ARNOLD, K., SPRINIVASAKUMAR, N., and FLANAGAN, T. D., Biomed. Biochim. Acta, 1991, 50, (2), 199–206.
  • Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. OKADA, H., INouE, Y., HEYA, T., UENO, H., OGAWA, Y., and ToGucm, H., Pharm. Res., 1991, 8, (6), 787–791.
  • Effects of a diluent on the retarded-release property of acrylate methacrylate-salicylic acid coacervates. OKOR, R. S., and YAHAYA, M. A., Pharm. Res., 1990, 7, (11), 1208–1209.
  • Preparation of micron-size monodisperse polymer microspheres having crosslinked struc-tures and vinyl groups. OKUBO, M., KATAYAMA, Y., and YAMAMOTO, Y., Colloid Polym. Sci., 1991, 269, (3), 217–221.
  • Preparation of micron-size monodisperse polymer particles by seeded polymerization utilizing the dynamic monomer swelling method. Ommo, M., SHIOZAKI, M., TsujnitRo, M., and TSUKUDA, V., Colloid Polym. Sci., 1991, 269, (3), 222–226.
  • Adsorption immobilization of trypsin enzymes onto polymer microspheres having hetero-geneous surfaces consisting of hydrophilic and hydrophobic parts. OKUBO, M., YAMAMOTO, Y., and KAMEI, S., Chem. Express, 1991, 6, (2), 145–148.
  • The effect of ginseng extracts on the photooxidation of liposome. I. The protective effect on the formation of hydroperoxides. PAIN TAI HONG, KIM YOUNG HO and lit JUN HEUNG, Koryo Insam Hakhoechi, 1990, 14, (3), 379–384.
  • The effect of ginseng extracts on the photooxidation of liposome. II. The effect on the changes of fluidity and lysis. PAIN TAI HONG and Y1 JUN HEUNG, Koryo Insam Hakhoechi, 1990, 14, (3), 385–390.
  • Liposomal delivery of biological response modifiers to macrophages. PAN, C. C., and FIDLER, I. J., Biotherapy, 1991, 3, (1), 55–64.
  • Pharmacokinetic characterization of phosphatidylserine liposomes in the rat. PALATINI, P., VIOLA, G., BIGON, E., MENEGUS, A. M., and BRUNI, A., Br. J. Pharmacol., 1991, 102, (2), 345–350.
  • Localized rifampicin albumin microspheres. PANDE, S., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1991, 8, (1), 87–93.
  • Hydroxyurea bearing albumin microspheres: preparation, characterization and evaluation.
  • PANDE, S. K., VYAS, S. P., and DIXIT, V. K., J. Microencapsulation, 1991, 8, (1), 9–20. Liposome targeting to tumor cells in vivo. PAPAHADJOPOULOS, D., and GABIZON, A., NATO ASI
  • Ser., Ser., A, 1990, 199 (Targeting Drugs 2), 95–101.
  • Polymorphonuclear leukocyte degranulation with exposure to polymethylmethacrylate nanoparticles. PAPATFIEOFANIS, F. J., and BARMADA, R., J. Biomed. Mater. Res., 1991, 25, (6), 761–772.
  • Lytic effects of melittin on vesicles on dipalmitoylphosphatidylcholine reconstituted with bacteriorhodopsin. PARANDOOSH, B., and CHERRY, R. J., Biochem. Soc. Trans., 1990, 18, (5), 942.
  • A photophysical model for diphenylhexatriene fluorescence decay in solvents and in phospholipid vesicles. PARASASSI, T., DE STASI°, G., Rusux, R. M., and GRATTON, E., Biophys. J., 1991, 59, (2), 466–475.
  • Liposomes loaded with nonionic contrast media: hepatosplenic computed tomographic enhancement. PASSARIELLO, R., PAVONER, P., PATRIZIO, G., DI RENZI, P., MASTANTUONO, M., and GIULIANII, S., Invest. Radiol., 1990, 25, (Suppl. 1), S92–S94.
  • A simple method for the preparation of liposomes for pharmaceutical applications: character-ization of the liposomes. PERRETT, S., GoLDING, M., and WILLIAMS, W. P., J. Pharm. Pharmacol., 1991, 43, (3), 154–161.
  • Virus production in microsphere-induced aggregate culture of animal cells. PERUSICH, C. M., GOETGHEBEUR, S., and Hu, W. S., Biotechnol. Tech., 1991, 5, (2), 145–148.
  • Liposomes from cell membranes lipid of wool and human hair. PETROVIC, S., KOERNER, A., and HOECKER, H., Schriftenr Dtsch. Wollforschungsinst (Tech. Hochsch. Aachen), 1990, 105 (Aachener Textiltag., 1989), 149–157.
  • Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice. PHILLIPS, N. C., and TSAO, M. S., Cancer Immunol. Immunother., 1991, 33, (2), 85–90.
  • Synthesis and liposome encapsulation of antisense oligonucleotide-intercalator conjugates. PIDGEON, C., WEITH, H. L., DARBISHIRE-WEITH, D., CUSHMAN, M., BYRN, S. R., CHEN, J. K., STOWELL, J. G., RAY, K., and CARLSON, D., Ann. N.Y. Acad. Sci., 1990, 616 (AIDS: Anti-HIV agents, therapies, and vaccines), 593–596.
  • Selective depletion of liver and splenic macrophages using liposomes encapsulating the drug dichloromethylene diphosphonate: effects on antimicrobial resistance. PINTO, A. J., STEWART, D., VAN ROOIJEN, N., and MORAHAN, P. S., J. Leukoc. Biol., 1991, 49, (6), 579–586.
  • Effect of selected variables on the preparation of gelatin-acacia microcapsules for aquacul-ture. PLANAS, M., FERNANDEZ REIRIZ, M. J., FERREIRO, M. J., and LABARTA, U., Aquacult. Eng., 1990 (1991), 9, (5), 329–342.
  • Liposomes injected intravenously in rats are taken up by pulmonary artery endothelial cells. POIANI, G. J., Fox, J. D., PENG, B. W., WILSON, F. W., and RILEY, D. J., Am. Rev. Respir. Dis., 1991, 143, (4, Part 2), A184.
  • Reticuloendothelial blockade enhances the effect of a liposome-encapsulated antiflbrotic agent in preventing collagen accumulation in pulmonary arteries of rats. POIANI, G. J., Sumx.A, J. M., Fox, J. D., Tozzi, C. A., and RILEY, D. J., Am. Rev. Respir. Dis., 1991, 143, (4, Part 2), A184.
  • The effect of melanins on oxidation of lecithin in liposomal membranes. PORCEBSKA-BUDNY, M., and STCEPIEN, K., Acta Biochim. Pol., 1990, 37, (1), 89–92.
  • Membrane potential measurements of the effect of melittin on lipid vesicles, erythrocytes and resealed ghosts. PORTLOCK, S. H., and CHERRY, R. J., Biochem. Soc. Trans., 1990, 18, (5), 939. Microcapsules of sodium 2,3-dimer captopropane sulfonate (unithiol). PORTNYAGINA, V. A., FEDOROVA, I. P., POCHINOK, T. V., TARAHOVSKII, M. L., ZADOROZHNAYA, T. D., and YATSENKO, K. V., Farmatsiya (Moscow), 1991, (2), 24–27.
  • Toxicities in rats with free versus liposomal encapsulated cisplatin. POTKUL, R. K., GONDAL, J., BITTERMAN, P., DRETCHEN, K. L., and RAHMAN, A., Am. J. Obstet. Gynecol., 1991, 164, (2), 652–658.
  • Effects of surfactant apoproteins on liposomes structure aggregation lysis fusion and ultra-structure. POULAIN, F. R., ALLEN, L., WILLIAMS, M. C., HAMILTON, R. L., and HAWGOOD, S., Pediatr. Res., 1991, 29, (4, Part 2), 327A.
  • Diffusion controlled systems: polymeric microcapsules. PRICE, J. C., Polym. Controlled Drug Delivery, CRC, Boca Raton, Fla., USA, 1991, pp. 1–14. Ed. P. J. Tarcha.
  • Reduction of the in vitro hemolytic activity of soybean lecithin liposomes by treatment with a block copolymer. QUIRION, F., and ST PIERRE, S., Biophys. Chem., 1991, 40, (2), 129–134. Liposome-encapsulated hemoglobin: an oxygen-carrying fluid. RABINOVICI, R., RUDOLPH, A. S., LIGLER, F. S., YUE, T. L., and FEUERSTEIN, G., Circ. Shock, 1990, 32, (1), 1–17. Controlled-release tablets of ethyl cellulose-coated salbutamol sulfate microcapsules.
  • RAGHUBANSHI, R. S., JAYASWAL, S. B., and SINGH, J., Pharmazie, 1991, 46, (2), 144–145.
  • Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate,, and free amphotericin B against fungal strains determined by using MIC, and minimal lethal concentration susceptibility studies, and time-kill curves. RALPH, E. D., KHAZINDAR, A. M., BARBER, K. R., and GRANT, C. W., Antimicrob. Agents Chemother., 1991, 35, (1), 188–191.
  • Kinetics of encapsulated yeast alcohol dehydrogenase dispersed in an organic solvent. RAMELMEIER, R. A., and BLANCH, H. W., Biocatalysis, 1990, 4, (2-3), 113–139.
  • Drug delivery systems 5A. Oral drug delivery. RANADE, V. V., J. Clin. Pharmacol., 1991, 31, (1), 2–16.
  • Polymerized liposomes as drug carriers. REGEN, S. L., Polym. Controlled Drug Delivery, CRC, Boca Raton, Fla., USA, 1991, pp. 83–97. Ed. P. J. Tarcha.
  • Test method for evaluating the permeability of intact prophylactics to viral-size microspheres under simulated physiologic conditions. RETTA, S. M., HERMAN, W. A., RINALDI, J. E., CAREY, R. F., HERMAN, B. A., and ATHEY, T. W., Sex. Transm. Dis., 1991, 18, (2), 111–118.
  • Ioxaglate-carrying liposomes: computed tomographic study as hepatosplenic contrast agent in rabbits. REVEL, D., COROT, C., CARRILLON, Y., DANDIS, G., ELOY, R., and AMIEL, M., Invest. Radio., 1990, 25, (Suppl. 1), 595–S97.
  • Liposomes as models to study the distribution of porphyrins in cell membranes. RICCHELLI, F., JORI, G., GOBBO, S., and TRONCHIN, M., Biochim. Biophys. Acta, 1991, 1065, (1), 42–48.
  • Proton dissociation dynamics in the aqueous layer of multilamellar phospholipid vesicles. ROCHEL, S., NACHLIEL, E., HUPPERT, D., and GUTMAN, M., J. Membr. Biol., 1990, 118, (3), 225–232.
  • Comparison of the action of lipoprotein lipase on triacylglycerols and phospholipids when presented in mixed liposomes or in emulsion droplets. RojAs, C., OLIVECRONA, T., and BENGTSSON OLIVECRONA, G., Eur. J. Biochem., 1991, 197, (2), 315–321.
  • Improved antitumor effect of the nitrosourea drugs tauromustine (TCNU) and carmustine (BCNU) on a rat liver adenocarcinoma after hepatic arterial administration with degradable starch microspheres. Roos, G., EL HAG, I. A., TEDER, H., and STENRAM, U., Anticancer Res., 1991, 11, (1), 13–16.
  • A new cationic liposome reagent mediating nearly quantitative transfection of animal cells. ROSE, J. K., BUONOCORE, L., and WHITT, M. A., Biotechniques, 1991, 10, (4), 520–525.
  • A physicochemical study of the morphology of progesterone-loaded microspheres fabricated from poly(D,L-lactide-co-glycolide). Rosimo, V., BENOIT, J. P., DEYME, M., THIES, C., and MADELMONT, G., J. Biomed. Mater. Res., 1991, 25, (5), 667–682.
  • Stabilization of lipid microstructures: fundamentals and applications. RUDOLPH, A. S., SINGH, A., PRICE, R. R., Goms, B., and GABER, B. P., NATO ASI Ser., Ser. A, 1990, 199 (Targeting Drugs 2), 103–115.
  • The elasticity of synthetic phospholipid vesicles obtained by photon correlation spectroscopy. RUTKOWSKI, C. A., WILLIAMS, L. M., HAINES, T. H., and CUMMINS, H. Z., Biochemistry, 1991,30, (23), 5688–5696.
  • Effect of 2.45 GHz microwave radiation on permeability of unilamellar liposomes to 5(6)-carboxyfluorescein. Evidence of non-thermal leakage. SAALMAN, E., NORDEN, B., ARVIDSSON, L., HAMNERIUS, Y., HOJEVIK, P., CONNELL, K., and KURUCSEV, T., Biochim. Biophys. Acta, 1991, 1064, (1), 124–130.
  • Study of the stability of hemoglobin-containing liposomes. SABLINA, M. A., USHAKOVA, I. P., SEREBRENNIKOVA, G. A., and EVSTIGNEEVA, R. P., Biol. Membr., 1991, 8, (3), 292–296.
  • Physical properties of liposomes. Part 2. SACKMANN, E., Parfuem Kosmet., 1991, 71, (1), 22, 24–25. 28–31.
  • Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin. SADASIVAN, R., MORGAN, R., FABIAN, C., and STEPHENS, R., Cancer Lett.,1991, 57, (2), 165–171.
  • Histological studies on the therapeutic effect of sustained-release microspheres of a potent LHRH agonist (leuprorelin acetate) in an experimental endometriosis model in rats. SAKURA, Y., MASAKI, T., SUDO, K., NOMURA, M., and SHINO, A., Endocrinol. Jpn., 1990, 37, (5), 719–729.
  • Small unilamellar vesicles are able to fuse with Mycoplasma capricolum cells. SALMAN, M., TARSHIS, M., and ROTTEM, S., Biochim. Biophys. Acta, 1991, 1063, (2), 209–216.
  • The 'adjuvant effect' of the polymorphic B-G antigens of the chicken major histocompatibility complex analyzed using purified molecules incorporated in liposomes. SALOMONSEN, J., ERIKSSON, H., SKJODT, K., LUNDGREEN, T., SIMONSEN, M., and KAUFMAN, J., Eur. J. immuna, 1991, 21, (3), 649–658.
  • Removal of liposomes with incompletely encapsulated enzyme using a monoclonal anti-alkaline phosphatase immunosorbent. SAMUEL, D., PATT, R., and TAYLOR, A. G., J. Immunol. Methods, 1990, 131, (1), 153–154.
  • Studies of conformation and interaction of the cyclohexenone and acetyl group of pro-gesterone with liposomes. SANCHEZ BUENO, A., WATANABE, S., SANCHO, M. J., and SAITO, T., J. Steroid Biochem. Mol. Biol., 1991, 38, (2), 173–179.
  • Phase diagram studies for microencapsulation of pharmaceuticals using cellulose acetate trimellitate. SANGHVI, S. P., and NAIRN, J. G., J. Pharm. Sci., 1991, 80, (4), 394-398. Highly stable liposomes from fluoroalkylated glycerophosphoquinolines. SANTAELLA, C., VIERLING, P., and RIESS, J. G., Angew Chem., 1991, 103, (5), 584–586.
  • Application of rnicrocarriers to Bacillus subtilis culture. SARIKAYA, E., and CIRAKOGLU, C., Mikrobiyol. Bul., 1990, 24, (2), 140–143.
  • Production of antibodies to dextran using liposome as adjuvant. SARKAR, A. K., and DAS, M. K., Immunol. Invest., 1991, 20, (3), 243–252.
  • Double fluorescent labeling method used for a study of liposomes. SAWAHARA, H., GOTO, S., and KINOSHITA, N., Chem. Pharm. Bull., 1991, 39, (1), 227–229.
  • pH-Responsive swelling of the ultrafine microsphere. SAWAI, T., YAMAZAKI, S., IKARIYAMA, Y., and AIZAWA, M., Macromolecules, 1991, 24, (8), 2117–2118.
  • Infective endocarditis-the effect of liposomes as carrier substance for alpha 1-antitrypsin and ampicillin. SCHAAF, H. S., BATES, W. D., HANEKOM, C., NEITELER, B. F., KRIEGLER, A. B., and VAN DER MERWE, P. L., S. Afr. Med. J., 1991, 79, (10), 588–590.
  • Phospholipid-biopolymer aggregates: challenging objects for the application of radioisotopes and useful tools for bioresearch. SCHAEFER, H., Zfl Mitt., 1989, 151, 85–101.
  • Intracellular distribution and destruction of liposomes after in vitro phagocytosis by alveolar macrophages. SCHOILEW, C., VELINOVA, M., and ITSCHEV, K., Arch. Exp. Veterinarmed, 1990, 44, (5), 649–654.
  • Evaluation of incorporation characteristics of mitoxantrone into unilamellar liposomes, and analysis of their pharmacokinetic properties, acute toxicity,, and antitumor efficacy. SCHWENDENER, R. A., FIEBIG, H. H., BERGER, M. R., and BERGER, D. P., Cancer Chemother. Pharmacol., 1991, 27, (6), 429–439.
  • Role of complements C3 and C5 in the phagocytosis of liposomes by human neutrophils.
  • SCIESZKA, J. F., MAGGIORA, L. L., WRIGHT, S. D., and CHO, M. J., Pharm. Res., 1991,8, (1), 65–69. Shape transformations of free, toroidal and bound vesicles. SEIFERT, U., Colloq. Phys., 1990, (C7, Int. Workshop Geom. Interfaces, 1990), C7-339-C7–344.
  • Controlled release of 3',5'-diester prodrugs of 5-fluoro-2'-deoxyuridine from poly-L-lactic acid microspheres. SEKI, T., KAWAGUCHI, T., ENDOH, H., ISHIKAWA, K., JuNi, K., and NAKANO, M., J. Pharm. Sci., 1990, 79, (11), 985–987.
  • The morphogenesis of liposomes viewed from the aspect of bending energy. SEKIMURA, T., and HOTANI, H., J. Theor. Biol., 1991, 149, (3), 325–338.
  • Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. SENIOR, J., DELGADO, C., FISHER, D., TILCOCK, C., and GREGORIADIS, G., Biochim. Biophys. Acta, 1991, 1062, (1), 77–82.
  • Liposomes in vivo: prospects for liposome-based pharmaceuticals in the 1990s. SENIOR, J. H., Biotechnol. Genet. Eng. Rev., 1990, 8, 279–317.
  • Peptide synthesis by microencapsulated chymotrypsin. SERRALHEIRO, M. L., EMPIS, J. M., and CABRAL, J. M., Ann. N.Y. Acad. Sci., 1990, 613, 638–642.
  • The effect of size of polystyrene particles on their retention within the rat peritoneal compartment, and on their interaction with rat peritoneal macrophages in vitro. SEYMOUR, L., SCHACHT, E., and DUNCAN, R., Cell. Biol. Int. Rep., 1991, 15, (1), 37–45.
  • Effect of solid dispersing agents on the formation of rosin microcapsules. SHEOREY, D. S., and DORLE, A. K., J. Microencapsulation, 1991, 8, (1), 79–82.
  • Effect of solvents on the characteristics of rosin walled microcapsules prepared by a solvent evaporation technique. SHEOREY, D. S., and DORLE, A. K., J. Microencapsulation, 1991, 8, (1), 71–78.
  • Entrapment of bioactive compounds within native albumin beads: IV. Characterization of drug release from polydisperse systems. SHEU MING THAU and SOKOLOSKI, T. D., Int. J. Pharm., 1991, 71, (1-2), 7–18.
  • Study on functional polymeric microspheres. Preparation of p-size polystyrene microspheres by dispersion polymerization. SHI JUNJIE and SUN ZONGHUA, Gongneng Gaofenzi Xuebao, 1990, 3, (2), 105–112.
  • Induction of in vitro and in vivo anti-tumor response by sensitization of mice with liposomes containing a crude butanol extract of leukemia cells and transferred inter-membranously with cell-surface proteins. SHIBATA, R., NOGUCHI, T., SATO, T., AKIYOSHI, K., SUNAMOTO, J., Slit xu, H., and NAKAYAMA, E., Int. J. Cancer, 1991, 48, (3), 434–442.
  • Microencapsulation of human cells: its effects on growth of normal and tumour cells in vitro. Swim, S. M., HOPWOOD, D., NEWMAN, E. L., and CUSCHIERI, A., Br. J. Cancer, 1991, 63, (5), 675–680.
  • Superior antiproliferative effects mediated by interferon-alpha entrapped in liposomes against a newly established human lung cancer cell line. SHIN, D. M., FIDLER, I. J., BUCANA, C. D., FAN, D., HONG, W. K., and KILLION, J. J., J. Biol. Response Modif., 1990, 9, (4), 355–360.
  • The sedimentation of bimodal distributions of unflocculated microspheres. SHOR, J. T., and WATSON, J. S., Sep. Sci. Technol., 1990, 25, (13-15), 2157–2170.
  • Toxicity of microencapsulated permethrin to selected nontarget aquatic invertebrates. SIBLEY, P. K., and KAUSHIK, N. K., Arch. Environ. Contam. Toxicol., 1991, 20, (2), 168–176.
  • Clinical pharmacokinetics of liposomal cis-bisneodecanoato-trans-R,R-1,2-diaminocyclo-hexaneplatinum(II) (L-NDDP). SIDDIK, Z. H., PEREZ SOLER, R., KHOKHAR, A. R., PAZDUR, R., ROH, M. S., FRANCIS, K., CHASE, J., and KRAEDEE, I. H., Proc. Am. Assoc. Cancer Res. Annu. Meet., 1991, 32, 176.
  • Tumor targeting with antibody-coupled liposomes: failure to achieve accumulation in xenografts and spontaneous liver metastases. SIEGFRIED, M., KREMPEL, H., WECKENMANN, H. P., SCHIRRMACHER, V., SINN, II., and STRICKER, H., Cancer Immunol. Immunother., 1990, 31, (5), 285–291.
  • Inhibition of human renal cancer by monoclonal antibody targeted methotrexate-containing liposomes in an ascites tumor model. SINGH, M., GHOSE, T., MEZEI, M., and BELITSKY, P., Cancer Lett., 1991, 56, (2), 97–102.
  • Distribution and retention of intratracheally administered liposomes in mouse lung. SMITH, L. J., and ANDERSON, J., Am. Rev. Respir. Dis., 1991, 143, (4, Part 2), A729.
  • Prevention of CTL and NK cell-mediated cytotoxicity by microencapsulation. SOON SIIIONG, P., Lu, Z. N., GREWAL, I., LANZA, R., and CLARK, W., Horm. Metab. Res. Suppl., 1990, 25, 215–219.
  • Properties of gelatin microcapsules obtained by the spray drying method from oil-water emulsions of different composition. Sovn.), V., DAKOVIC, Li., and DoRic, P., Kern. Ind., 1990, 39, (9), 429–434.
  • An improved method for the microencapsulation of liver microsomes for use in extra-corporeal detoxication. STANGE, J., DUMMLER, W., BRUGMANN, E., FALKENHAGEN, D., SIEGMUND, E., ERNST, B., and DAUTZENBERG, H., Z. Med. Lab. Diagn., 1990, 31, (7), 366–370.
  • Biodegradable microspheres. XIII: immune response to the DNP hapten conjugated to polyacryl starch microparticles. STJAERNKVIST, P., DEGLING, L., and SJOHOLM, I., J. Pharm. Sci., 1991, 80, (5), 436–440.
  • Liposomes and biotherapeutics. STORM, G., WILms, H. P., and CROMMELIN, D. J., Biotherapy, 1991, 3, (1), 25–42.
  • The bioavailability of griseofulvin in liposomes. STOZEK, T., and BORYSIEWICZ, J., Pharmazie, 1991, 46, (1), 39–41.
  • Characteristics of spectrin-induced leakage of extruded, phosphatidylserine vesicles. SUBBARAO, N. K., MACDONALD, R. I., TAKESHITA, K., and MACDONALD, R. C., Biochim. Biophys. Acta, 1991, 1063, (1), 147–154.
  • A possible function of phosphonolipid effect of ceramide 2 aminoethylphosphonate on liposomal glycolipid antigen-antibody reaction. SUGITA, M., ITONORI, S., FUJI, H., I TASAKA, O., and HORI, T., Mem. Fac . Educ. Shiga Univ. Nat. Sci. Pedagog. Sc., 1990, (40), 35–40.
  • Influence of partition parameter on release of drug from adjuvant-containing charged film microcapsules. SULTZBAUGH, K. J., SPEAKER, T. J., ANGELINI, J., and SPEAKER, T. J., J. Microencapsulation, 1990, 7, (4), 505–509.
  • Effective transfer of membrane proteins from intact cells to liposomes and preparation of liposomal vaccines. SUNAMOTO, J., AKIYOSHI, K., GOTO, M., NOGUCHI, T., SATO, T., NAKAYAMA, E., S14IBATA, R., and SHIKU, H., Ann. N.Y. Acad. Sci., 1990, 613, 116–127.
  • CD4 and CD7 molecules as targets for drug delivery from antibody bearing liposomes. Suzum, H., ZELPHATI, 0., HILDEBRAND, G., and LESERMAN, L., Exp. Cell Res., 1991, 193,(1), 112–119.
  • Studies on liposomal ferromagnetic particles and a technique of high frequency inductive heating: in vivo studies of rabbits. Suzum, S., ARAI, K., KOIKE, T., and OGUCHI, K., J. Jpn. Soc. Cancer Ther., 1990, 25, (11), 2649–2658.
  • Purification and reconstitution of membrane carrier proteins. SZEWCZYK, A., and NALCECZ, M. J., Postepy Biochem., 1989, 35, (4), 469–492.
  • The future of liposomal drug delivery. SZOKA, F. C. JR., Biotechnol. Appl. Biochem., 1990, 12, (5), 496–500.
  • Liposomes as antigen vehicles to increase immunogenicity: effects of variation of structural characterics. TAN, L. S., Ann. Acad. Med. Singapore, 1991, 20, (1), 78–83.
  • Pharmacokinetic behavior of charged liposomes in vivo and the influence of charge, lipid composition and pH on electrophoretic mobility in vitro. TAN, L. S. K., and GREGORIADIS, G., Asia Pac. J. Pharmacol., 1990, 5, (4), 297–303.
  • Interaction of the herbicide atrazine with model membranes. I: Physico-chemical studies on dipalmitoyl phosphatidylcholine liposomes. TANFANI, F., AMBROSINI, A., ALBERTINI, G., BERTOLI, E., CURATOLA, G., and ZOLESE, G., Chem. Phys. Lipids, 1990, 55, (2), 179–189.
  • Preparation and characterization of pancreatic lipase immobilized in Eudragit-matrix. TELEFONCU, A., DINCKAYA, E., and VORLOP, K. D., Appl. Biochem. Biotechnol., 1990, 26, (3), 311–317.
  • Tantalum loaded silicone microspheres as particulate emboli. THANOO, B. C., and JAYAKRISHNAN, A., J. Microencapsulation, 1991, 8, (1), 95–101.
  • Controlled transdermal mucolytic delivery system. THASSU, D., and VYAS, S. P., Drug Dev. Ind. Pharm., 1991, 17, (4), 561–576.
  • Liposomal vaccine: influence of antigen association on the kinetics of the humoral response. THERIEN, H. M., LAIR, D., and SHAntim, E., Vaccine, 1990, 8, (6), 558–562.
  • Synergistic interaction of antioxidatnts in protection of liposomes and cholesteryl ester-phospholipid dispersions against oxidation. THOMAS, C. E., and OHLWEILER, D. F., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (4), A886.
  • Acute effects of liposome aerosol inhalation on pulmonary function in healthy human volunteers. THOMAS, D. A., MYERS, M. A., WICHERT, B., SCHREIER, H., and GONZAI,EZ ROTHI, R. J., Chest, 1991, 99, (5), 1268–1270.
  • An improved method for the preparation of liposomal gadolinium-DTPA. Ionophore-mediated active entrapment of gadolinium. TILCOCK, C. P., AHKONG, Q. F., and PARR, M., Invest. Radiol., 1991, 26, (3), 242–247.
  • The parenteral controlled release of liposome encapsulated chloroquine in mice. TITULAER, H. A., ELING, W. M., CROMMELIN, D. J., PEETERS, P. A., and ZUIDEMA, J., J. Pharm. Pharmacol., 1990, 42, (8), 529–532.
  • Effect of vitamin E-containing liposome on the development of in vitro xylose cataract. TORII, H., OKADA, H., MAJIMA, Y., OHTA, Y., and ISHIGURO, I., Invest. Oplahalmol. Visual Sci., 1991, 32, (4), 749.
  • Effect of phospholipid composition in liposome containing vitamin E on its transport into cultured lenses. TORII, H., HATTORI, H., MAJIMA, Y., OHTA, Y., ISH IGURO, I., and NAGAMURA, Y Atarashii Ganka, 1991, 8, (1), 99–103.
  • Interaction of the membrane-bound 0-lactate dehydrogenase of Escherichia coli with phospholipid vesicles and reconstitution of activity using a spin-labeled fatty acid as an electron acceptor: a magnetic resonance and biochemical study. TRUONG, H. T., PRATT, E. A., and Ho, C., Biochemistry, 1991, 30, (16), 3893–3898.
  • Albumin microspheric ascorbic acid and adenine to preserve erythrocyte viability and oxygen carrying capacity. TRUTER, E. J., Med. Lab. Sci., 1990, 47, (3), 199–203.
  • Effect of halothane on the fusion of liposomes. TSDCHIYA, M., TOMODA, M., UEDA, W., and HIRAKAWA, M., Igaku no Ayumi, 1990, 155, (7), 475–476.
  • Monoclonal antibodies immunoconjugates and liposomes as targeted therapeutic systems. TYLE, P., and RAM, B. P., P. Tyle and B. P. Ram (Eds). Targeted Diagnosis and Therapy Series, Vol. 3: Targeted Therapeutic Systems. 388 p. Marcel Dekker, Inc., Monticello, New York, USA, 1990, pp. 3–22.
  • Targeted diagnosis and therapy series, Vol. 3. Targeted therapeutic systems. TYLE, P., and RAM, B. P., P. Tyle and B. P. Ram (Ed.). Targeted Diagnosis and Therapy Series, Vol. 3: Targeted Therapeutic Systems. 388p. Marcel Dekker, Inc., 1990.
  • Preparation of enteric-coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: the effect of swine serum on micromeritic properties. TZAN, Y. L., Lix, S. Y., WENC, C. N., and LEE, C. J., Biotechnol. Tech., 1991, 5, (2), 139–144.
  • Evaluation of phase transition temperature of liposomes by using tautomerism of benzoyl-acetoanilide and effects of cholesterol. UENO, M., KATOH, S., KOBAYASHI, S., TOMOYAMA, E., OBATA, R., NAKAO, H., OHSAWA, S., KOYAMA, N., and MORITA, Y., Langmuir, 1991, 7, (5), 918–922.
  • Colorimetric assay for cellular activity in microcapsules. Ut.tipAG, H., and SEFTON, M. V., Biomaterials, 1990, 11, (9), 708–712.
  • Paramagnetic liposomes as magnetic resonance contrast agents. UNDER, E., TiLcocx, C., AHKONG, Q. F., and FRITZ, T., Invest. Radio., 1990, 25, (Suppl. 1), S65–S66.
  • Microcapsule applied to chemoembolization of cancer. UNNO, K., and GOTO, A., Funtai Kogaku Kaishi, 1991, 28, (2), 92–98.
  • Membrane stabilizing effect of vitamin E: existence of a hydrogen bond between alpha-tocopherol and phospholipids in bilayer liposomes. URANO, S., KITAHARA, M., KATO, Y., HASEGAWA, Y., and MATSU°, M., J. Nutr. Sci. Vitaminol., 1990, 36, (6), 513–520.
  • Liposome-based vehicles for topical delivery. USTER, P. S., D. W. Osborne and A. H. Amann (Eds). Drugs and the Pharmaceutical Sciences, Vol. 42: Topical Drug Delivery Formulations. 420p. Marcel Dekker, Inc.: New York, N.Y., USA, 1990, pp. 327–348.
  • Liposomal cyclosporin immunosuppressant. VADIEI, K., Drugs Future, 1991, 16, (3), 208–209. Purification and reconstitution of a collagen-binding heat-shock glycoprotein from L6myoblasts. VAILLANCOURT, J. P., and CATES, G. A., Biochem. J., 1991, 274, (3), 793-798. Normolipidemic activity of liposomal-encapsulated superoxide dismutase in rats. VAILLE, A., and JADOT, G., Free Radical Res. Commun., 1990, 11, (4-5), 241–250.
  • A fluorescence method for the determination of the molecular weight cut-off of alginate-polylysine microcapsules. VANDENBOSSCHE, G. M. R., VAN OOSTVELDT, P., and REMON, J. P., J. Pharm. Pharmacol., 1991, 43, (4), 275–277.
  • Size-based separation of polystyrene nanoparticles by capillary electrophoresis. VAN ORMAN, B. B., and MCINTIRE, G. L., Am. Lab., 1990, 22, (17), 66–67.
  • Analytical separation of polystyrene nanospheres by capillary electrophoresis. VAN ORMAN, B. B., and MCINTIRE, G. L., J. Microcolumn. Sep., 1989, 1, (6), 289–293.
  • Effect of sugars on freeze-thaw and lyophilization of liposomes. VEMURI, S., Yu, C. D., DEGROOT, J. S., WANGSATORNTHNAKUN, V., and VENKATARAM, S., Drug Dev. Ind. Pharm., 1991, 17, (3), 327–348.
  • Drug release rate method for a liposome preparation. VEMURI, S., Yu, C. D., PUSHPALA, S., and ROOSDORP, N., Drug Dev. Ind. Pharm., 1991, 17, (2), 183–192.
  • Modulation of lipid peroxidation of liposomes and micelles by antioxidants and chelating agents. VIGO PELFREY, C., and NGUYEN, N., C. Vigo Pelfrey (Ed.). Membrane Lipid Oxidation, Vol. II. 209 pp. CRC Press, Boca Raton, Florida, USA, 1991, pp. 135–150.
  • Raman spectroscopic studies of dimyristoylphosphatidic acid and its interactions with ferricytochrome c in cationic binary and ternary lipid-protein complexes. VINCENT, J. S., and LEVIN, I. W., Biophys. J., 1991, 59, (5), 1007–1021.
  • The design of a diagnostic test system based on magnetic sorbents and liposomes. VLADIMTSEVA, I. V., PLEKHANOVA, N. G., SMIRNOVA, V. I., and ZAKREVSKII, V. I., Zh. Mikrobiol. Epidemiol. Immunobiol., 1990, (10), 103–106.
  • Effect of tetracyclines on liposome mineralization. VOGEL, J. J., J. Dent. Res., 1991, 70, (Spec. Issue, April), 494.
  • Preparation and characterization of HSA-propranolol microspheres for nasal administration. VYAS, S. P., BHATNAGAR, S., GoGot, P. J., and JAIN, N. K., Int. J. Pharm., 1991, 69, (1), 5–12.
  • Preparation and dissolution test in vitro of sustained-release microcapsules of indomethacin. WANG GAOFENG, LIANG QIANG and Luo YUNXIAN, Zhongguo Yaoxue Zazhi, 1990, 25, (9), 536–538.
  • Degradation of poly(ester) micropheres. WANG, H. T., PALMER, H., LINHARDT, R. J., FLANAGAN, D. R., and SCHMITT, E., Biomaterials, 1990, 11, (9), 679–685.
  • Serum concentration and distribution in the liver, lung, heart and kidney of platinum after hepatic arterial injection in the form of cis-diammine dichloroplatinurn microcapsule in rabbits. WANG, Y., Chung Hua Wai Ko Tsa Chih, 1990, 28, (11), 686–688.
  • Fabrication of uniform-sized liposomes using microfabricated structures. WASHIZU, M., and HASHIMOTO, T., Toyoda Kenkyu Hokoku, 1990, (43), 17–25.
  • Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of 'stealth' lipids. WASSEF, N. M., MATYAS, G. R., and ALviNG, C. R., Biochem. Biophys. Res. Commun., 1991, 176, (2), 866–874.
  • Inhibitory effect of liposomes containing sulfatide or cholesterol sulfate on syncytium formation induced by bovine immunodeficiency virus-infected cells. WATARAI, S., ONUMA, M., YAMAMOTO, S., and YASUDA, T., J. Biochem. (Tokyo), 1990, 108, (4), 507–509.
  • Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. WATTS, P. J., DAVIES, M. C., and MELIA, C. D., Crit. Rev. Ther. Drug Carrier Syst., 1990, 7, (3), 235–259.
  • Microencapsulated dog and rat islet xenografts into streptozotocin-diabetic and NOD mice. WEBER, C. J., ZABINSI, S., KOSCHITZKY, T., RAJOTTE, R., WICKER, L., PETERSON, L., D'AGATI, V., and REEMTSMA, K., Horm. Metab. Res. Suppl., 1990, 25, 219–226.
  • Chemistry and biology of immunotargeted liposomes. WEINER, A. L., P. Tyle and B. P. Ram (Eds). Targeted Diagnosis and Therapy Series, Vol. 3: Targeted Therapeutic Systems. 388 p. Marcel Dekker, Inc., Monticello, New York, USA, 1990, pp. 305–336.
  • Human recombinant migration inhibitory factor (RMIF) encapsulated in liposomes activates monocyte-derived macrophages to kill Leishmania donovani and potentiates immune response to soluble protein antigen. WEISER, W. Y., FURLONG, S. T., and DAVID, J. R., FASEB (Fed. Am. Soc. Exp. Biol.) J., 1991, 5, (4), A627.
  • Covalent binding of peptides at liposome surfaces. WEISSIG, V., LASCH, J., and GREGORIADIS, G., Pharmazie, 1990, 45, (11), 849–850.
  • A method for preparation of liposomes with encapsulated peptide antigens and surface-linked sugar residues. WEISSIG, V., LASCH, J., and GREGORIADIS, G., Pharmazie, 1991, 46, (1), 56–57.
  • Liposome mediated in vitro transfection of pancreatic islet cells. WELSH, N., ()BERG, C., HELLERSTROM, C., and WELSH, M., Biomed. Biochim. Acta, 1990 (1991), 49, (12), 1157–1164.
  • Microcapsules through polymer complexation. I. Complex coacervation of polymers contain-ing a high charge density. WEN, S., XIAONAN, Y., and STEVENSON, W. T. K., Biomaterials,1991, 12, (4), 374–384.
  • Controlled release of benzoyl peroxide from a porous microsphere polymeric system can reduce topical irritancy. WESTER, R. C., PATEL, R., NACHT, S., LEYDEN, J., MELENDRES, J., and MAIBACH, H., J. Am. Acad. Dermatol., 1991, 24, (5, Part 1), 720–726.
  • Biodistribution and clearance of contrast-carrying MREV liposomes. WHITE, C., SLIFKIN, M., SELTZER, S. E., BLAU, M., ADZAMLI, I. K., and ADAMS, D. F., Invest. Radiol., 1990, 25, (10), 1125–1129.
  • Circular dichroism and fluorescence studies on interaction of calmodulin (CaM) with purified calcium-magnesium ATPase of erythrocyte ghosts. WRZOSEK, A., FAMULSKI, K. S., and PIKULA, S., Acta Biochim. Pol., 1990, 37, (1), 173–176.
  • Optical characteristics of coating films containing polymer microspheres. YABUTA, M., and SASAKI, Y Polym. Mater. Sci. Eng., 1990, 63, 772–776.
  • On the relation between the dispersion state of polymer microspheres in the coating films and the film properties. YABUTA, M., and SASAKI, Y Polym. Mater. Sci. Eng., 1990, 63, 767–771.
  • Effect of sulfatide-inserted liposomes containing entrapped adriamycin on metastasized cells in lymph nodes. YAGUCHI, T., YAMAUCHT, M., TAKAGI, H., OHISHI, N., and YAGI, K., J. Clin. Biochem. Nutr. 1990, 9, (2), 79–86.
  • Delivery of adriamycin entrapped in sulfatide-containing liposomes to lymph nodes. YAGUCHI, T., YAMAUCHI, M., TAKAGI, H., HAYASHI, Y., and YAGI, K., Drug Delivery Syst., 1991, 6, (1), 47–50.
  • Microbial degradation of crude oil on the sea surface by adding nutrient microcapsules. YAMANE, A., OKADA, M., and MURAKAMI, A., Suishitsu Odaku Kenkyu, 1990, 13, (1), 48–53.
  • Antioxidative activities of tocotrienols on phospholipid liposomes. YAMAOKA, M., CARRILLO, M. J. H., NAKAHARA, T., and KOMIYAMA, K., J. Am. Oil Chem. Soc., 1991, 68, (2), 114–118.
  • Potential value of cetylmannoside-modified liposomes as carriers of macrophage activators to human blood monocytes. YAMASHITA, C., SONE, S., OGURA, T., and KIWADA, H., Jpn. J. Cancer Res., 1991, 82, (5), 569–576.
  • Enhancing effect of cetyl mannoside on targeting of liposomes to Kupffer cells in rats. YAMASHITA, C., MATSUO, H., AKIYAMA, K., and KIWADA, H., Int. J. Pharm., 1991, 70, (3), 225–234.
  • Enhancing effect on monocytes survival of reconbinant human macrophage colony-stimulating factor encapsulated in cetylmannoside-modified liposomes. YAMASHITA, C., SONE, S., OGURA, T., and KIWADA, H., Drug Delivery Syst., 1991, 6, (1), 19–24.
  • Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. YANAGIE, H., TomITA, T., KOBAYASHI, H., Fuji', Y., TAKAHASHI, T., HASUMI, K., NARIUCHI, H., and SEKIGUCHI, M., Br. J. Cancer, 1991, 63, (4), 522–526.
  • Efficacy of cytosine arabinoside encapsulated in biocompatible liposomes in L615 leukemic mice. YANG XIGFEN, WANG MIN, MA YUFEN and FAN Qociu, Zhonghua Xueyexue Zazhi, 1990, 11, (10), 525–527.
  • The study of microencapsulation for acetaminophen granules. YEN, M. K., Rau, M. Y., and WANG, D. P., Chin. Pharm. J., 1991, 43, (2), 165–174.
  • Protective effect of liposome-encapsulated superoxide dismutase on acetaminophen-induced rat hepatocellular necrosis. YOSHIJI, H., NAKAE, D., SHIRAIWA, K., Tsujii, T., and KONISHI, Y Kanzo, 1990, 31, (9), 1046–1052.
  • Interaction of liposomes with cultured cells: possible involvement of lipid peroxidation in cell growth inhibition. YOSHIOKA, S., OKANO, Y., MIZUKAMI, Y., and NOZAWA, Y., Chem. Pharm. Bull., 1990, 38, (11), 3090–3093.
  • Photoinduced, polyelectrolyte-driven release of contents of phosphatidylcholine bilayer vesicles. You HONG and TIRRELL, D. A., J. Am. Chem. Soc., 1991, 113, (10), 4022–4023.
  • Anti-metastatic activity in vivo of MDP-L-alanyl-cholesterol. (MTP-Chol) entrapped in nanocapsules. Yu, W. P., BARRATT, G. M., DEVISSAGUET, J. P., and PUISIEUX, F., Int. J. Immunopharmacol., 1991, 13, (2-3), 167–173.
  • Microencapsulation of DNA-recombinant cells and its application in production of HBsAg. YUAN, Z. Y., LI, S. Y., Li, X., CHEN, P. Y., WANG, Y., and Wu, X. F., Ann. N.Y. Acad. Sci ., 1990, 613, 338–346.
  • Preparation of liposome-encapsulated superoxide dismutase and its pharmacokinetics. ZHANG, J., and ZHANG, T. M., Chin. J. Pharm., 1991, 22, (2), 93.
  • Leakage kinetics of camptothecin from polyphase liposomes. ZHANG QINGMIN and Gu XuEotu, Shenyang Yaoxueyuan Xuebao, 1990, 7, (2), 113–117.
  • Three-wavelength spectrophotometry determination of camptothecin in polyphase lipo-somes. ZHANG QINGMIN, WANG PENG and Gu XUEQIU, Shenyang Yaoxueyuan Xuebao, 1991, 8, (1), 48–51.
  • Preparations and properties of cucurbitacin BE liposome. ZHANG XIAOXIANG and Su DESEN, Zhongcaoyao, 1991, 22, (2), 62–65.
  • In vivo contraceptive studies of controlled release microspheres of norgestrel. ZHU MINGHUA, SONG CUNXIAN, WANG PENGYAN, WANG FUJUN, TANG LINA, JIANG YAOHONG and SHI HUALIAN, Zhongguo Shengwu Yixue Gongcheng Xuebao, 1990, 9, (3), 197–201.
  • Features of incorporation of several antibiotics into erythrocyte ghosts—a system of targeted delivery of chemotherapeutic drugs. ZHUMADILOV, ZH. SH., and MAKARENKOVA, R. V., Antiobiot. Khimioter., 1990, 35, (11), 54–56.
  • Pharmacokinetics of kanamycin during targeted delivery to the liver in erythrocyte ghosts in animals with experimental acute cholecystitis. ZHUMADILOV, ZH. SH., and MAKARENKOVA, R. V., Antibiot. Khimioter., 1990, 35, (11), 37–38.
  • Biopharmaceutical evaluation of a tablet dosage form made from ethyl cellulose-encapsulated aspirin particles. ZIA, H., FALAMARZIAN, M., RAISI, A., MONTASERI, H., and NEEDHAM, T. E., J. Microencapsulation, 1991, 8, (1), 21–28.
  • New developmental tendencies in product and active substance encapsulation (Part 1). ZIOLKOWSKY, B., Seifen, Oele, Fette, Wachse, 1991, 117, (5), 190–192.
  • Interaction of the herbicide atrazine with model membranes. II: Effect of atrazine on fusion of phospholipid vesicles. ZOLESE, G., AMBROSINI, A., BERTOLI, E., CURATOLA, G., and TANFANI, F., Chem. Phys. Lipids, 1990, 56, (2-3), 101–108.
  • Targeting behavior of hepatic artery injected temperature sensitive liposomal adriamycin on tumor-bearing rats. ZOU YIYU, UENO MASAHARU, YAMAGISHI MAKIKO, HORIKOSHI ISAMU, YAMASHITA IWAO, TAZAWA KENJI and GU XUEQIU, Sel Cancer Ther., 1990, 6, (3), 119–127.
  • Influence of surface charge on aggregation of phospholipid vesicles induced by poly(ethylene glycol). ZSCHOERN1G, 0., ARNOLD, K., MACHILL, H., LACHMANN, U., and HEROLD, W., Stud. Biophys., 1990, 137, (3), 153–160.
  • Some physical properties of polypropylene-phenolic microsphere blends. ZUCHOWSKA, D., and HLAVATA, D., Eur. Polym. J., 1991, 27, (4-5), 355–357.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.